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125I-labelled ovine prolactin was used to test for the
presence of specific prolactin binding sites in the membranes
prepared from tissues of the snake Ptyas mucosa by means of
radioreceptor assay. High levels of prolactin receptor binding
was found in snake kidney and large intestine membranes of both
sexes. The binding of 125I-labelled ovine prolactin to snake
renal membranes was characterized. The binding was time-,
temperature- and protein-dependent. The presence of Ca2+ in
the incubation medium enhanced the binding, with optimal
concentrations at 10- 20 mM. Specificity of prolactin
receptor binding was established by employing different
hormones as the displacing species in the radioreceptor assay.
Human growth hormone and ovine prolactin have high activity in
displacing the binding of 1251-labelled ovine prolactin to
snake kidney and large intestine membranes, while bovine growth
hormone and human chorionic somatomammotropin showed only low
activity of binding. Scatchard analysis of 'the binding of
125I-labelled ovine prolactin to snake kidney membranes
suggested the presence of a single class of binding sites with
dissociation constant in-the nM range. 1251-labelled bovine
growth hormone showed no significant binding to snake.
membranes.
Snake pituitary extract was found to be capable of
displacing the binding of both 125I-labelled ovine prolactin
and 1251-labelled bovine growth hormone to female rat liver
membranes, suggesting the presence of prolactin-like and growth
hormone-like activities in snake pituitaries. The snake
prolactin-like and growth hormone-like activities were further
identified by various purification and isolation techniques.
Snake prolactin-like and growth hormone-like activities were
non-glycoproteins. Both of them were unadsorbed to
Concanavalin A-Sepharose and concentrated in the ConA I
fraction. The prolactin-like and growth hormone-like
activities in fraction ConA I can be separated by ion-exchange
chromatography on DEAE- cellulose. Snake growth hormone-like
activity was unadsorbed on DEAE-cellulose while snake
prolactin-like activity was adsorbed. The active fractions
were further purified by gel filtration on Sephadex G-50.
Fraction All showed the highest activity in displacing the
binding of 125I-labelled bovine growth hormone to female rat
liver membranes and possessed no contamination with high
molecular weight components. 125I-labelled fraction All can
also bind to female rat liver and late pregnant rabbit liver
membranes. The potency of the binding of fraction All to these
membranes was lower than that of bovine growth hormond but it
was significantly higher than that of ovine prolactin. The
result suggested that fraction All was partially purified snake'
growth hormone-like activity with a molecular weight of about
20,000 daltons. Fraction H'll showed the highest activity in
displacing the binding of 125I-labelled ovine prolactin to
female rat liver membranes, but the degree of purity of
fraction H'll was relatively low. It possessed multiple bands
in SDS-polyacrylamide gel electrophoresis. Fraction H'll
exhibited significant displacement on the binding of 125j_
labelled ovine prolactin to female rat liver as well as snake
kidney and large intestine membranes. The result suggested
that fraction H'll was partially purified prolactin-1ike
activity with a molecular weight of about 16,000 daltons.
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CHAPTER 1 INTRODUCTION
1.1 Growth hormone and its biological functions
The ability of pituitary extracts to stimulate growth was
first recognized by Evans and Long in 1921. They discovered
the presence in an emulsion of the pituitary anterior lobe of
growth-promoting substances which were able to produce
gigantism in rats. Attempts to purify the responsible factors
soon followed. The first success came from Li et al. (1945),
who isolated a highly purified growth hormone (GH) of bovine
origin. Since then the isolation of GHs from various
vertebrates was begun. The availability of purified GH
preparations from various species allowed the detailed study of
the biological functions of this hormone.
The obvious major action of GH is to promote overall
somatic growth( Cheek and Hill, 1975; Paladini et al., 1983;
Wallis et al., 1985a). The growth-promoting effects of GH
apply both to the skeleton and the soft tissues, especially
muscle. GH stimulates cartilage growth which will eventually
give rise to bone. The administration of GH in vivo to a
suitable animal stimulates both cell division of chondrocytes
and production of cartilage matrix components. GH can also
stimulate the increase in width of the tibial epiphyses of
hypophysectomized rats. This particular effect has been widely
used as a standardized in vivo bioassay system for GHs( Wallis
et al., 1985a). In addition to promoting skeleton and soft
tissue growth, there is a marked positive balance in the
metabolism of nitrogen, phosphorus, potassium, calcium and even
sodium. When GH is administrated to animals in vivo. it causes
general nitrogen retention; levels of urinary nitrogen and
blood urea fall. These effects may be largely due to a
stimulation of protein synthesis which occurs in many tissues,
most notably in skeletal muscle and liver. GH stimulates
protein synthesis in the liver in vivo, and in perfused liver
in vitro. GH enhances the incorporation of leucine into muscle
proteins. In the perfused liver it also stimulates amino acid
uptake and the synthesis of all forms of RNA. GH also has
biological actions on lipid and carbohydrate metabolism.- GH
causes an initial drop in the level of plasma non-esterified
fatty acids, followed by a prolonged increase in their levels.
This appears to be due to an increased utilization of lipids-
increased uptake of non-esterified fatty acids by muscle
somewhat preceding increased output by adipose tissue. The
overall effect is that GH tends to divert energy metabolism
from carbohydrate catabolism to lipid catabolism- £he hormone
acting to counteract the action of insulin. The actions of GH
on lipid metabolism are particularly marked in man, where. GH
levels are elevated on fasting. GH has both insulin-like and
diabetogenic effects. In suitable animal models both effects
can be demonstrated: a transient hypoglycaemia followed by
prolonged hyperglycaemia. The latter appears to be a
consequence of reduced glucose uptake by peripheral tissues and
is often associated with elevated insulin levels. GH has many
in vitro effects on adipose tissue, including stimulation of
lipolysis and actions on glucose utilization. These effects
accord well with its in vivo actions.
GHs exhibit species specificity. All mammalian GHs are
about equally active in the rat tibia bioassay. Highly
purified avian( Farmer et al.. 1974; Harvey and Scanes, 1977;
Leung et al., 1984), reptilian and amphibian GHs( Farmer
et al., 1976a) are also active in the rat tibia bioassay but
with lower potencies, whereas teleostean GH is inactive in the
assay( Farmer et al., 197 6b). However, non-primate GHs are
not active in man or monkey. Human GH (hGH) possesses
lactogenic activity in addition to its somatogenic activity.
The exact mechanism of GH to produce and regulate growth
is still unknown but it is evident that many of the biological
actions of GH is mediated through a family of insulin-like
peptides, the somatomedins. The growth-promoting effects of GH
on cartilage in mammals appear to be mediated by somatomedins
( Phillips and Vassilopoulon-Sel1in, 1980; WallMs et. al..
1985a).
GH has been isolated from a wide variety of mammals( Table
1.1) and from many non-mammalian vertebrates( Table 1.2).
Among those GHs isolated the most important one is the
purification of hGH by Li et al. (1956). The hGH preparation
was active in GH bioassays and proved to be effective for
clinical purposes. The earlier methods for purification of GH
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employed mainly selective precipitation and extraction
techniques, but recently a range of alternative purification
methods has been described using the more powerful methods of
chromatography and electrophoresis. Tissue culture of
pituitary cells was also available and GH has been purified
from the medium of cultured pituitary cells( Kishida et al.,
1987). These give higher yields and purity. The recent
advancement of recombinant DNA technology has commenced a new
direction of research: cDNAs of various vertebrate GHs have
been cloned and expressed in bacteria( Table 1.3) and large
scale production of GHs is now available( George et aJL.,
1985). These lead to a large varieties of application of GHs
in different animals.
The purified GH in all species studied is a protein with
molecular weight of about 20,000 daltons containing a single
polypeptide chain of about 200 amino acid residues. GH has a
single homologous tryptophan residue t at locus 85 or
corresponding positions and two homologous disulfide bonds.
The isoelectric points of purified GHs fall into the range of
4.9 to 6.8. The protein is not conjugated with carbohydrate or
lipid moieties. It has been found that GH is not a single
entity but a collection of similar proteins with variant forms
which share functions and are immunologically related
( Paladini et al.. 1983). Highly purified GHs are still
heterogeneous mainly due to the multiplicity of different GH
components rather than to the presence of other protein
impurities. Multiple forms of GH have been detected in several
Table 1.3 Various growth hormones cloned and expressed in
bacteria.
Species Year References
Chum salmon (Oncorhvnchus keta)


























preparations of the hGH, rat GH and bovine GH (bGH) by Ellis
et aJL. (1978). These forms could be isolated by
electrophoresis and gave markedly different bioassay to
radioimmunoassay (RIA) ratios. Highly specific antibodies to
various forms of GHs have been prepared.
Hayashida (1973) has reviewed the immunological properties
of purified GH and pituitary extracts of various vertebrates.
Cross reactivity has been found in all non-primate GHs if a
monkey against rat GH antiserum is employed. On the other
hand, cross reactivity has only been found in monkey and human
GHs if a rabbit against hGH antiserum is employed. These
indicate that all GHs studied share some common immunological
determinants while primate GHs share some additional
determinants which probably are not present in non-primate GHs.
Highly purified submammalian GHs including avian GH, reptilian'
GH, amphibian GH and GH from primitive bony fishes also showed
cross reactivity to the monkey against rat GH antiserum,
suggesting the presence of common determinants. Highly
purified teleostean-GH has been prepared by Farmer et al.
(1976b). Specific antiserum against the purified teleostean GH
has been demonstrated to cross react to the homologous GH only.
Specific antibodies against various GHs have been developed and
the RIA of GH is now readily available( Harvey and Scanes,
1977; Leung et ad., 1984).
The amino acid compositions of GHs have been determined
either from the purified proteins or from the cloned cDNA of
GHs. All purified mammalian GHs are rich in leucine, glutamate
and asparate residues. The alanine content is also rich in
many mammalian GHs except for hGH. Purified non-mammalian GHs
also show similar amino acid compositions. Avian GHs( Farmer
et al., 1974) including duck, pigeon, turkey and chicken GHs
( Harvey and Scanes, 1977; Leung et al., 1984), reptilian and
amphibian GHs( Farmer et a_l., 197 6a), and even teleostean GH
which has been demonstrated to be inactive in rat tibia
bioassay are all of similar amino acid compositions. Salmon GH
( Kawauachi et al., 1986) and eel GHs( Kishida et al., 1987)
also have similar amino acid compositions.
The amino acid seguences of various purified GHs have been
elucidated. Comprehensive reviews by Nicoll et al. (1986a and
1986b) have compared the amino acid sequences of various
purified GHs. Figure 1.1 shows the amino acid sequence of bGH.
All the purified mammalian GHs have two disulfide bonds. In
bGH, there is a large loop formed by the disulfide bond between
cysteine 53 and cysteine 164. There is also a small loop
formed near the carboxy terminal by the disulfide bond formed
between cysteine 181 and cysteine 189. Comparison of the amino
acid sequences of GHs from different species reveals a
considerable amount of variation. The detailed three-
dimensional structure for GH is not known, mainly because
crystals suitable for X-ray diffraction studies have not been
prepared. Use of the physical techniques of circular dichroism
and optical rotatory dispersion has provided some information
about the secondary structure of GHs from various species. All
H2N
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figure 1.1 The primary structure of bovine growth hormone.
purified GHs contain a good deal of a-helix, 50-60% of the
polypeptide chain having this conformation. In the study of
the relationships between the structure and function of GH,
limited digestion of the hormone is employed to determine which
features of the primary structure are required for activity.
Many indications suggest that peptides representing only part
of the amino acid sequence of GH may retain significant
biological activity. Nicoll et al. (1986a) have reviewed the
biological activity of digested GH fragments and the effects of
recombinant GH fragments.
1.2 Growth hormone receptor
It is generally believed that the initial physiological
event of hormone actions involves binding of hormone to its
specific receptor in the target cells. For polypeptide
hormones, the specific receptors are located on the plasma
membrane of the target cell. A large number of these hormone
receptors have been identified( Roth, 1973) The initial
studies of GH receptors located in different tissues and organs
were conducted by using autoradiography after injection of the
125I-labelled GHs.
When 125I-labelled hGH was injected into male rats,
radioactivity became associated primarily with the kidney and
to a lesser extent the liver, adipose tissue and adrenal cortex
( De Kretser et al., 1969). 3H-labelled hGH was also
concentrated in the kidney, liver and adrenal glands after
injection into rats or guinea pigs, and the radioactivity
associated with skeletal muscle was also found in large amount
( Collipp et ad., 1966). Distribution of 14C-labelled or
12 5i_iabelled bGH after injection into rats has also been
studied. Concentration of radioactivity in liver, kidney and
spleen was rapid, but subsequently declined. Concentration of
radioactivity in heart and skeletal muscle, pancreas and
intestine occurred more slowly, but was less transitory. After
2 hours the bulk of the label was associated with skeletal
muscle( Retegui-Sardou et aJL., 1977). These studies suggest
that cellular receptors for GH are rather widely distributed.
Concentration of the labelled hormone in liver, kidney and
spleen may reflect a role of these organs in metabolizing the
hormone and removing it from the circulation.
A great deal of work has been carried out on the ability
of tissue and cell preparations to bind GH. The interaction of
GHs with their specific receptors on the plasma membrane was
studied by radioreceptor assays (RRA) employing highly purified
25T-labelled GHs. Lesniack et al. (1973) have firstlv
developed a sensitive RRA employing xI-hGH as the radioactive
ligand. They demonstrated specific 125I-hGH binding on
cultured human lymphocytes. Tsushima et a.1. (1973) have
demonstrated binding of 125I-hGH to liver microsomal membranes
of pregnant rabbits. The binding was specific for GHs. GHs of
human, monkey, bovine and ovine origin can all inhibit the
binding of 125I-hGH, while the inhibition by human prolactin
(PRL) is minimal. Posner et al. (1974) have described the
distribution of specific binding of 125I-hGH in various
mammalian tissues. The classical target tissues of GH actions
including diaphragm, adipose tissue and skeletal muscle in rat
showed little binding activity. High and significant specific
binding of 125I-hGH was found in liver membranes from pregnant
rats and rabbits. Specific 125I-hGH binding was also found in
many rabbit membranes( adrenal, mammary gland and ovary).
Most workers tend to study the hepatic GH receptor mostly
because the liver content of GH receptor has been found to be
greater than that of most other tissues. Postel-Vinay et al.
(1976) have demonstrated the presence of two binding sites for
125I-hGH in rat liver membranes. One is the lactogenic site
from which 125I-hGH bound can be displaced by PRL but not non-
primate GHs. The other is the somatogenic site which cannot
bind PRL. The ability of hGH to bind both lactogenic and
somatogenic binding sites correlates well with the finding that
hGH has both somatogenic and lactogenic activities. Herington
et al. (1976) have characterized the binding of 125I-hGH to
liver microsomal membrane from female rats. The binding was
dependent on time, temperature, pH, membrane concentration and
concentration of 125I-hGH. The binding process was: in a
saturable and reversible manner. The specificity of the
binding site showed a lactogenic pattern. Ovine PRL (oPRL)
showed considerable competition for the binding site. Non-
primate GH and non-related hormones all showed negligible
competition. Scatchard analysis of the binding data revealed
the presence of two classes of binding sites with dissociation
constants (Kd) of 0.16 nM and 3.33 nM.
The presence of somatogenic sites can be demonstrated by
using 125I-labelled bGH (125I-bGH) or 125I-labelled non-primate
GHs as ligand. Ranke et ad. (1976) have reported specific
125I-bGH binding to isolated rat hepatocytes. The somatogenic
sites are present in both males and females. The binding is
specific for various GHs. Human, rat and bovine GHs can
compete for the binding to the somatogenic sites whereas PRL
has no binding activity. Maes et aJL. (1983)- have obtained
similar results. Herington and Veith (1977) have also
demonstrated the presence of somatogenic sites in rabbit liver.
Hughes (1979) have characterized the binding of rat and rabbit
GHs to rabbit liver membranes. They demonstrated the presence
of two classes of binding sites for non-primate GHs
( Kd= 0.1 nM and 5.88 nM). Hung and Moore (1984) have-
obtained similar results by a homologous RRA involving 125I-bGH
and bovine liver membranes. Somatogenic sites were also found
in pregnant mouse liver microsomal membranes( Posner, 1976),
isolated rat adipocytes( Gavin III et al., 1982), mouse
fibroblasts( Murphy et al., 1983) and adult rabbit lung
microsomal membranes( Amit et al., 1987).
Specific GH binding sites have been demonstrated in
cultured human lymphocytes. Lesniack et al. (1973 and 1974)
employed 125I-hGH to characterize the binding. The binding was
specific for hGH. Non-primate GHs and unrelated hormones had
no binding activity. The Kd of the binding was found to be
0.77 nM. Roguin et al. (1981) have reported the existence of
hGH specific binding sites in female rabbit kidney membranes.
The binding possessed a lactogenic type of binding specificity
with a Kd of 56 pM. Roguin et al. (1982) have also solubilized
the hGH binding sites from female rabbit kidney membranes which
retained high binding affinity (Kd= 13 pM).
Besides the work of Roguin et al. (1982), Herington and
Veith (1977) have also solubilized somatogenic GH binding sites
from rabbit liver. Bonifacino et al. (1981) also demonstrated
a lactogenic type of binding specificity in solubilized binding
sites from rat liver membranes. Solubilized rabbit liver
bindincr sites also showed similar properties. A detailed study
of the somatogenic receptor for GHs was carried out by Waters
and Friesen (1979) who purified a GH receptor from pregnant
rabbit liver membranes by means of affinity chromatography
The purified receptor possessed high affinity for the binding
of bGH and low affinity for oPRL. The molecular weight of the
receptor was about 300,000. The purified material showed one
main band and two minor bands on sodium dodecyl sulphate (SDS)
polyacrylamide gel electrophoresis. The main band corresponded
to a molecular weight of about 75,000 to 80,000, which could be
interpreted as indicating a tetrameric receptor. Recently the
GH receptor has been cloned from rabbit liver( Leung et al.,
1987). The primary structure of the cloned receptor was
deduced from the DNA sequence. The cloned GH receptor has
about 62 0 amino acid residues and a molecular weight of about
70,000 daltons. The cloned receptor shows one major
hydrophobic region of about 24 amino acid residues centrally
located in the molecule. This is presumably the transmembrane
domain which separates the extracellular, amino-terminal, GH
binding domain from the intracellular, carboxy-terminal,
signalling domain.
The presence of specific GH binding sites in non-mammalian
vertebrates was first reported by Posner et aJL. who
demonstrated specific binding of 125I-hGH in pigeon liver and
frog kidney microsomal membranes. The binding was due to the
presence of lactogenic sites in these tissues. Marques et al.
(1978) have injected 125I-hGH and 125I-bGH to turtle
( Chrvsemvs dorbiani) and found that the radioactivity was
basically concentrated by the liver and kidney. When labelled
GH was injected together with an excess of unlabelled hormone,
only liver showed a significant reduction of radioactivity
uptake. The reduction was dose dependent. The study suggested
the presence of somatogenic binding sites in liver. Tarpey and
Nicoll (1985) have reported the presence of xI-bGH specific
binding in liver membranes of sturgeon( Acioenser
transmontanus). They have also reported a much lower but
significant specific binding of 125I-bGH in liver membranes of
a teleost( Gillichthys mirabilis). No significant specific
binding was detected on liver membranes of pigeon, turtle,
bullfrog, tilapia or leopard shark. The binding of 125I-bGH to
fish liver membranes showed a somatogenic type of binding
specificity but Scatchard analysis revealed the presence of two
classes of binding sites in sturgeon liver membranes
( Kd= 3.23 pM and 10 pM). Liver membranes from Gillichthvs
contained only one single class of binding sites with a Kd of
149 pM.
Homologous RRA have also been developed by using highly
purified non-mammalian GHs as the radioactive ligand. Highly
purified 125I-labelled tilapia( Sarotherodon mossambicus) GH
bound to tilapia microsomal liver membranes( Fryer, 1979a).
The homologous GH preparation had highest affinity for the
binding. GH preparations from several vertebrates at high
concentrations displayed competition for the tilapia GH binding
site and PRLs had much lower binding affinity to the binding
sites. Scatchard analysis showed a single class of binding
sites with a Kd of 67 pM. Moreover, 125I-labelled tilapia GH
demonstrated specific binding to liver microsomal membrane
fractions of the teleosts Gillichthvs mirabilis. Salmo-
gairdneri and Oncorhvrchus tschawvtscha but not to those of an
amphibian Necturus maculosus or a bird Coturnix i aponica.
w
Slight but significant specific binding was observed with the
microsomal membrane fractions of tilapia kidney and gill, and
of rat liver. Leung et aJL. (1984) have purified chicken GH and
IPS
developed a homologous RRA employing I-labelled chicken GH.
Specific GH binding was detected in chicken liver microsomal
0
membranes. Purified bGH was as active as chicken GH in binding
to the chicken liver membranes, but oPRL was less active in
A.
displacing 125I-labelled chicken GH binding. Nicoll et al.
(1986b) have compared various vertebrate GH binding sites in
terms of binding specificities.
1.3 Prolactin and its biological functions
The occurrence of a factor in pituitary extracts which
could stimulate mammary growth and lactation was first
demonstrated sixty years ago by Strieker and Grueter (1928).
Subsequent research attempted to identify the hormone and to
study its chemical and biological properties. The hormone was
first purified by Lyons (1937) and White et al. (1937). The
purified hormone was named prolactin for its predominant
stimulating effects on mammary growth and lactation. Highly
purified preparations of PRL have been obtained from various
species. However, extensive structure-function and
physiological studies of PRL have been concentrated mainly on
the ovine hormone. Its structure, shown in Figurel.2,
comprises a single polypeptide chain of 199 amino acids (Li,
1978). It has a molecular weight of 23,000 daltons and an
isoelectric point of 5.73. There are three loops formed by
three disulfide bridges.
PRL has been reported to have more than 5 different
actions in a number of diverse biological systems( Nicoll and
Bern, 1972; Nicoll, 1975; Clarke and Bern, 1980), but the
effects of PRL on the mammary gland are the most widely studied
physiological aspects of the hormone. These mammotropic
effects are reflected in the alternative term for PRL
( mammotropin, lactogenic hormone). The first indication that
the adenohypophysis is involved in mammary function came in
1928 from studies by Strieker and Grueter. They reported that
nh2
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Figure 1.2 The primary structure of ovine prolactin.
the injection of a crude pituitary extract induced lactation in
pseudopregnant rabbits, which had well developed mammary
glands. Soon thereafter Riddle and Braucher (1931) reported
that crude pituitary extracts stimulated production of milk
by the crop sac of pigeons. It was later established that the
same adenohypophysial principle was responsible for the milk
production and for mammary secretion( Lyons, 1937; Riddle and
Bates, 1939).
The gonadotropic action of PRL was established by Astwood
(1941) and by Evans et al. (1941) when they demonstrated that
the effectiveness of crude pituitary extracts in maintaining
functional corpora lutea in rats was attributable to the PRL
contained therein. This finding gave origin to an additional
synonym for PRL, namely luteotrophin.
The osmoregulatory function of PRL was first studied by
Pickford and Phillips (1959) who found that oPRL enabled
hypophysectomized killifish( Fundulus heteroclitus) to
survive in freshwater. This finding prompteU subsequent
investigation of other species. Many euryhaline fishes were
found to be PRL-dependent for survival in freshwater but' many
fishes were not. There is no accurate generalization regarding
PRL-:dependency for freshwater survival of teleosts( Clarke and
Bern, 1980). Basically PRL acts on multiple sites in fishes
to decrease salt and electrolyte loss and water influx( Bern,
1975). The osmoregulatory functions of PRL have also been
studied in other vertebrate groups including amphibians,
reptiles, avians and mammals( Nicoll and Bern, 1972; Nicol]
1981; Loretz and Bern, 1982).
Besides these three major physiological functions, PRL
also takes part in somatotropic effects, behavioral effects and
metamorphosis in amphibians( Bern and Nicoll, 1968; Nicoll,
1974; Bern, 1983).
The action mechanisms of PRL in its target cells are still
unknown. Most of the works are concentrated on mammary gland
epithelial cells and cultured mammary gland cells in order to
find out second messengers responsible for the action of the
hormone. There are many mechanisms proposed including the
cyclic AMP pathway, internalization of PRL, prostaglandin
production and cation transport( Rosen, 1981; Nolin, 1985;
Wallis et al., 1985b). Shiu et al. (1987) have demonstrated'
that PRL can consistently induce the synthesis of specific
proteins in human breast cancer cells.
Highly purified PRL preparations have been obtained from
various vertebrates including many non-mammalian species
( Table 1.4). All mammalian PRLs possess lactogenic
activities and are active in the pigeon crop sac stimulation
bioassay. They are all similar in structure, containing about
200 amino acid residues and rich in asparate, glutamate and
leucine residues. All the purified mammalian PRLs have a
molecular weight of about 23,000 daltons. Most of them are
slightly acidic. PRL is more soluble in alkaline buffers( Li,
Table 1.4 Purified prolactins from various non-mammalian
vertebrates.
Species Year References
Blue shark (Prionace glauca)
Tilapia (Sarotherodon mossambicus)
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1975). Usually PRL is unglycosylated, only one glycosylated
form has been reported to have lactogenic activities( Pankov
and Butnev, 1986).
Purified PRLs from non-mammalian species have greater
heterogenity. Avian PRL( Scanes et al_., 1975) shows
lactogenic activity in the pigeon crop sac bioassay. The amino
acid composition of the purified avian PRL is similar to that
of mammalian PRL preparations. Purified turkey PRL( Burke and
Papkoff, 1980) also yields similar results. There is only one
reptilian PRL purified( Chang and Papkoff, 1985). The
purified turtle PRL is similar to mammalian PRL preparations.
It possesses lactogenic activities and has similar amino acid
compositions as compared to the mammalian preparations.
Greater variance occurs in teleostean PRL. Purified
tilapia PRL possesses no lactogenic activity but sodium-
retaining activity( Farmer et al., 1977). More structural
studies have shown that the hormone has a lower molecular
weight( about 19,900 daltons) and lacks the smallloop in the
amino terminal which is present in many mammalian PRLs( Farmer
and Papkoff, 1979). However, chinook salmon PRL possesses
both lactogenic activity and sodium-retaining activity( Prunet
and Houdebine, 1984). Similar results have been obtained by
Yamamoto and Kikuyama (1981) for purified amphibian PRL.
Purified bullfrog PRL is more potent than mammalian PRL in
promoting collagen synthesis in the tadpole tail fin.
Moreover, the purified tilapia PRL is active in the rat tibia
bioassay, and cross-reacts with rat GH and snapping turtle GH
antisera.
PRL has diverse functions in various vertebrate groups
( Nicoll, 1974). Among these reported functions nearly all are
based on the study of mammalian PRLs. The purification of PRLs
from various non-mammalian groups supplied more detailed study
of the specificity of various PRL preparations. These studies
suggest that PRL and GH may be originated from a common
ancestral molecule, thus acquiring many of their functions in
higher vertebrates during the course of evolution.
1.4 Prolactin receptor
The presence of PRL receptor was first studied by •»
injecting the radio-labelled hormone into animals followed by
detection of its presence in various organs and tissues. The
earliest reports( Birkinshaw and Falconer, 1972; Rajaniemi,
1974; Bullough and Wallis, 1977) showed that the label was
concentrated mainly in the liver and kidney, with some in the
ventral prostate, testis, mammary glands( especially during
lactation) and corpus luteum after injection of 125I-labelled
PRL into rats, mice and rabbits. Turkington (1971) had first
demonstrated the specific binding of 125I-oPRL to mid-pregnant
mouse mammary tissues. Shiu et ad. (1973) have also
demonstrated specific PRL binding in rabbit mammary gland
membranes. Specific PRL binding was also found in female rat
liver, rabbit adrenal, sheep uterus and frog kidney microsomal
membranes( Posner et al., 1974). Many of the studies were
carried out by using 125I-hGH because it can bind to both the
lactogenic and somatogenic sites.
Subsequent studies showed that specific binding of
oPRL was also found in pigeon crop sac( Forsyth et al.,
1978), rat kidney( Marshall, 1975; Mountjoy et al., 1979)
and rat adrenal( Marshall, 1975) microsomal membranes.
Shiu and Friesen (1974) have characterized the binding of
125I-oPRL to rabbit mammary gland membranes. The binding was
time, temperature and pH dependent. Scatchard analysis
suggested the presence of a single class of receptor with a Kd
of 0.34 nM. Maes et ajL. (1983) had obtained similar results in
the binding studies of 125I-oPRL to rat liver membranes
( Kd =1.03 nM).
Many studies were concentrated on the binding of 125I-oPRL
to non-mammalian membranes. The first report oi 125I-oPRL
specific binding to non-mammalian membranes was by Posner
et al. (1974) who demonstrated the specific binding of 125i-
oPRL to frog kidney membranes. A more detailed study by White
and Nicoll (1979a and 1979b) showed that 125I-oPRL specific
binding in bullfrog( Rana catesbeiana) increased during the
metamorphic climax. They also demonstrated specific binding in
tail and gill microsomal membranes. The renal PRL binding
sites exhibited a lactogenic type of specificity and had a high
binding affinity of( Kd= 1 nM). White (1981) examined the
occurrence of PRL binding sites in many amphibian tissues.
Renal PRL specific binding was evident in many anurans and
urodeles. Only the more aquatic and larval-like species, Siren
lacertina. Crvotobranchus alleqaniensis. Necturus maculosus and
Xenopus laevis showed low or no specific binding for PRL.
Specific binding of PRL to urinary bladder was high and
significant in two urodeles, transformed Ambvstoma tigrinum and
Cryptobranchus alleqaniensis; and specific binding to liver and
gut membranes was generally low. The renal PRL binding showed
high affinity( Kd= 0.2- 0.6 nM) and a lactogenic type of
binding specificity( Nicoll and White, 1985). Amphibian
renal PRL binding sites showed highest affinity for binding
oPRL and hGH. The binding affinity of non-primate GH and
placental lactogen was generally low. Dunand et al. (1985)
have also demonstrated specific binding of PRL in cultured
epithelial cells from toad Bufo marinus urinary bladder and
cultured Xenopus laevis kidney-derived cell line. More recent
reports( d'Istria, 1987; Tarpey and Nicoll, 1987) also
confirmed and characterized the renal PRL binding sites in many
amphibian species( Ambvstoma tigrinum, Rana catesbeiana and
Rana esculenta).
The ontogeny of specific PRL binding sites in amphibian
tissues was demonstrated by Carr et al. (1981). Renal specific
binding of PRL was low in premetamorphic tadpoles( White and
Nicoll, 1979a; White, 1981; Nicoll and White, 1985), but
specific PRL binding to liver and tail fin microsomal membranes
was evident( Carr and Jaffe, 1980). During metamorphosis,
the specific binding sites of PRL in tadpole liver, kidney and
tail fin membranes increased and reached a maximum at stage
XVIII. A gradual decrease then followed. These changes of PRL
binding to different tissues can be mimicked by thyroxine
administration( Carr et al.. 1981; White et al., 1981) which
can increase PRL binding to amphibian kidney membranes.
The presence of renal PRL binding sites in amphibians
suggests that PRL may have some osmoregulatory functions in
these animals. Evidence indicating direct relation between
renal PRL binding sites and osmoregulation came from the work
of Guardabassi et al. (1987) which demonstrated a reduction of
PRL specific binding to the membranes from the kidney and
epidermis of dehydrated Xenopus laevis.
There is only one report on PRL binding to reptilian
tissues. Tarpey and Nicoll (1987) have demonstrated specific
renal PRL binding sites in the turtle Pseudemvs scriota
elegans. The binding -is highly specific for oPRL and hGH, and
bGH had very low potency in the binding assay.
In avians specific PRL binding sites have been found in
the pigeon crop sac( Kledzik et al., 1975; Shani et a_l., 1977;
Forysth et al., 1979) and ring dove( Streptopelia risoria)
liver membranes( Buntin et al., 1984). The binding is highly
specific for oPRL and has a high affinity( Kd= 0.3 nM).
Although PRL has a significant role in osmoregulation in
fishes, specific PRL binding does not correlate well with its
functions in fishes. No specific renal binding can be detected
in cyclostomes if 125I-oPRL is used as the radioactive ligand.
In teleost only the cichlid tilapia, Sarotherodon mossambicus.
exhibits specific PRL binding to kidney membranes if highly
purified 125I-labelled tilapia PRL is used as the radioactive
ligand( Fryer, 1979b). Nicoll et al. (1980) have also
demonstrated renal specific PRL binding to tilapia kidney
membranes by means of 125I-oPRL binding assays. Edery et al.
(1984) employed 125I-oPRL to demonstrate specific oPRL binding
in tilapia liver, ovary and testis membranes, suggesting the
possibility that PRL may possess diverse functions in teleosts.
PRL receptors have been solubilized from many mammals
( Gravish, 1983; Yamada and Donner, 1984; Berthon, 1987;
Dusanter-Fourt et al., 1987). The reported properties of the
purified PRL receptors vary among different groups of
researchers. Carr and Jaffe (1981 and 1982) have solubilized
PRL receptors from tadpole liver, tail fin and kidney
membranes. The molecular weight and charges of the tadpole PRL
receptors are different from those of the rat liver PRL
receptors, suggesting the presence of different PRL receptors
in different tissues and animals. Ovarian PRL receptors have
also been solubilized from luteinized rat ovaries using the
bifunctional reagent disuccinimidyl suberate( Bonifacino and
Dufau, 1984). Cross-linking experiments revealed that ovarian
lactogenic receptors are molecules with an approximate
molecular weight of about 80,000 containing a subunit with a
molecular weight of approximate 40,000 bearing the recognition
site for the hormone. Recently PRL receptors have been cloned
from rat liver( Boutin et al., 1988). The primary structure
of the rat liver PRL receptor has been deduced from the
sequence of the cloned cDNA. The sequence begins with a
putative 19 amino acid signal peptide followed by the 291 amino
acid receptor that includes a single 24 amino acid
transmembrane segment. In spite of fact that the PRL receptor
has a much shorter cytoplasmic region than the GH receptor,
there is strong localized sequence identity between these two
receptors in both the extracellular and cytoplasmic domains,
suggesting that the two receptors originated from a common
ancestor.
1.5 Aims of the present investigation
Holmes and Balls (1974) described the presence of PRL-
secreting cells( acidophils type 1, Al 'cells) and GH-
secreting cells( acidophils type 2, A2 cells) in the
pituitaries of many reptilian species including turtles( Order
Chelonia), snakes( Order Squamata), and lizards( Order
Squamata). Moreover, Chang and Papkoff (1985) had
demonstrated that partially purified PRL from snake Cobra sp.
and Ptvas sp. showed cross reaction in the sea turtle PRL RIA.
This suggests the presence of PRL-like activity (PLA) and GH-
like activity (GHLA) in snake pituitaries. However there are
only very limited reports on the purification of reptilian GH
( Farmer et al., 1976a) and PRL( Chang and Papkoff, 1985)
though GH and PRL have been purified from many other non-
mammalian vertebrates. These reports described the
purification of PRL and GH from turtles but there is no report
on the purification of PRL and GH from snakes.
In the present study, the properties of snake pituitary
PLA and GHLA are studied by various isolation and
chromatographic techniques. The PLA is monitored by its
ability to displace 125I-oPRL specific binding to female rat
liver microsomal membranes. The PRL RRA is highly specific for
PRL or PLA. Prunet et al. (1977) had shown that pituitary
extracts of non-mammalian species had the ability to displace
125I-oPRL specific binding to mammalian lactogenic receptors.
Prunet and Houdebine (1984) had employed PRL RRA to monitor the
presence of PLA during the purification of PRL from chinook
salmon pituitaries. The presence of GHLA in snake pituitaries
is detected by its ability to displace 125I-bGH specific
binding to female rat liver membranes. The bGH RRA is highly
specific for GHs and PRL has very low potency to displace the
binding of GH to the hepatic somatogenic receptor( Postel-
Vinay, 1976). Monkey against rat GH antiserum also showed
cross reaction with reptilian pituitary extracts( Hayashida,
1973), suggesting the presence of structural similarities
between reptilian and mammalian GHs. Thus it is possible to
detect the GHLA from snake pituitaries by means of a bGH RRA.
The present study aims at identifying the properties of snake
PLA and GHLA which might lead to the purification of PRL and
GH from snake pituitaries.
Specific PRL binding sites have been characterized in many
non-mammalian species. Among them the renal PRL specific
binding in amphibians is the most evident. The presence of
renal PRL binding sites in amphibians and teleosts may reveal
some correlation to the putative osmoregulatory functions of
the hormone in these species. However, there are only a
limited number of reports on the osmoregulatory functions of
PRL in reptiles( Chan et al., 1970; Brewer and Ensor, 1980a
and 1980b) and PRL binding sites in reptiles( Tarpey and
Nicoll, 1987). PRL specific binding has only been found in
turtle kidney membranes but there is no report on PRL specific
binding in snakes. Specific bGH binding sites have not been
found in reptilian species but Marques et al. (1979) had showed
that radioactivity was concentrated in liver and kidney after
injection of 125I-bGH into the turtle Chrvsemvs dorbicmi.
Another aspect of the present study aims at identifying
specific PRL and GH binding sites in various snake tissues by
means of RRA using 125I-oPRL and 125I-bGH as radioactive ligand
respectively.
The common rat snake( common water snake), Ptvas mucosa.
is common in many habitats throughout Hong Kong and south China
( Karsen et al., 1986). It is one of the representatives of
the family Colubridae. Most of the other snakes also belong to
this family. The snake lives in a terrestrial habitat and is
commonly seen for sale in local snake shops. In the present
study the snake Ptvas mucosa was chosen because there is no
report on the purification of snake PRL and GH. Only Chang and
Papkoff (1985) have reported the presence of a partially
purified PRL from the same genus( Ptvas).
CHAPTER 2 MATERIALS AND METHODS
2.1 Animals
2.1.1 Rats
Adult female Sprague-Dawley rats, weighing about 250 g,
were used to prepare liver microsomal membranes for I-oPRL
and 125I-bGH binding experiments.
2.1.2 Snakes for pituitary collection
Heads of mature common rat snakes( Ptvas mucosa) were
collected from a local snake shop. Snake heads were frozen in
-20°C immediately after decapitation of the animals. The snake
heads were dissected after arrival at the laboratory. Whole
pituitary glands were removed and kept frozen at -70°C. Snake
pituitary glands were collected throughout the year except for
the hibernation period in winter. The present stud was based
on a collection of about 2,000 snake pituitary glands. Each
snake pituitary gland weighed about 9 mg.
2.1.3 Snakes for binding studies
Mature male and female common rat snakes were purchased
from a local snake shop. The snakes were sacrificed by
decapitation, and the following tissues and organs were
H 0 R
collected fresh to prepare microsomal membranes for I-oPRL
and 125I-bGH binding studies: brain, lung, heart, liver,
kidney, pancreas, spleen, oesophagus, stomach, small intestine,
large intestine, ovary, testis, muscle and adipose tissue.
2.2 Materials
All reagents and chemicals used were of analytical grade
or the best quality available. The suppliers of the chemicals
used are listed in Table 2.1.
2.3 Affinity chromatography on Concanavalin A-Sepharose
Concanavalin A (Con A) binds molecules which contain a-D-
mannopyranosyl, a-D-glucopyranosyl and sterically related
residues( Goldstein et al., 1965). Con A-Sepharose is Con A
coupled to Sepharose 4B by the cyanogen bromide method.
Affinity chromatography on Con A-Sepharose canbe used to
separate non-glycoproteins from glycoproteins. The adsorbed
glycoproteins can be eluted by using high concentrations of
carbohydrates.
The Con A-Sepharose column (37 cm x 1.35 cm) was
equilibrated with buffer B (50 mM Tris-HCl, pH 7.8, containing
1 mM CaCl2, 1 mM MgCl2, 0.5 M NaCl and 0.2 mM dithiothreitol)
before the application of snake pituitary extract. After
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Human chorionic gonadotropin (hCG)
Human chorionic somatomammotropin (hCS)
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Sigma
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application of the sample, the column effluent was monitored by
measuring the UV absorbance at 280nm. After the unadsorbed
protein peak( Figure 4.1 and 4.2) had been eluted from the
column, the adsorbed glycoproteins were eluted with buffer B
containing 1 M a-methyl-D-glucoside. The column was
regenerated by running carbohydrate-free buffer B through it
for several bed volumes.
2.4 Gel filtration on Sephadex G-50
The Sephadex G-50 powder was preswollen in 50 mM ammonium
bicarbonate buffer( NH4HC03). The column was packed and run
at ice-cold temperature. The packed Sephadex G-50 column
(76.2 cm x 0.95 cm) was equilibrated with the same buffer
before sample application. The column was calibrated with blue
dextran 2000 (MW 2,000,000), chymotrypsinogen A (MW 25,000) and
cytochrome c (MW 12,500). The elution profile is shown in
Figure 2.1. Samples were eluted with the buffer and the eluent
was monitored by UV absorbance at 280nm.
2.5 Gel filtration on Sephadex G-100
The Sephadex G-100 gel was preswollen in 50 mM ammonium
bicarbonate buffer. The column was packed and run at ice-cold
temperature. The packed Sephadex G-100 column (73 cm x 2.3 cm)
Was equilibrated with the above buffer before sample
application. The column had been calibrated prior to use.
Figure 2.1 Gel filtration of molecular weight marker
proteins on Sephadex G-50.
The Sephadex G-50 column was calibrated by
elution of blue dextran 2000 (MW 2,000,000),
chymotrypsinogen A (MW 25,000) cytochrome c
(MW 12,500) and tyrosine. Blue dextran 2000 was
eluted out first (peak I) and
chymotrypsinogen A was eluted out as the
shoudler of peak I. Cytochrome c was eluted out
subsequently (peak II) and tyrosine was
completely retarded. Column dimension:
76.2 cm x 0.95 cm. Flow rate: 19 mlh.
Fraction size: 1.6 ml. Buffer: 50 mM NH4HCO3.
Blue dextran 2000 (MW 2,000,000), BSA (MW 67,000), egg albumin
(MW 45,000), chymotrypsinogen A (MW 25,000) and cytochrome c
(MW 12,500) were used as marker proteins and the elution
profile is shown in Figure 2.2. The selectivity curve for the
Sephadex G-100 column constructed using the molecular weight
standards is shown in Figure 2.3. Samples were eluted with the
above buffer and the eluent was monitored by UV absorbance at
280nm.
2.6 Ion-exchange chromatography on DEAE-cellulose
The DEAE-cellulose column was packed and run at ice-cold
temperature. The column was equilibrated with 10 mM ammonium
bicarbonate buffer (pH 9.0) prior to use. The unadsorbed
material was eluted with the same buffer. The adsorbed
material was eluted with increasing concentrations of the
ammonium bicarbonate buffer. The eluent was monitored by UV
absorbance at 280nm, pooled according to peaks, then
lyophilized.
2.7 SDS-Polyacrylamide gel electrophoresis
The column fractions were studied by polyacrylamide slab
gel electrophoresis in the presence of sodium dodecyl sulphate
(SDS). Electrophoresis of column fractions in 10%, 12.5% or
15% polyacrylamide slab gels in the presence of 0.1% (wv) SDS
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Figure 2.2 Gel filtration of molecular weight markers on
Sephadex G-100.
The Sephadex G-100 column was calibrated by
elution of a mixture of molecular weight markers
including blue dextran 2000 (MW 2,000,000;
peak II), BSA (MW 67,000; peak II), egg albumin
(MW 45,000; peak III), chymotrypsinogen A
(MW25,000; peak IV), cytochrome c (MW 12,500;
peak V) and tyrosine (peak VI). Column
dimension; 73 cm x 2.3 cm. Flow rate:
12.8 mlh. Fraction size: 4.8 ml. Buffer:
50 mM NH4HCO3.
Figure 2.3 Selectivity curve of the Sephadex G-100 column.
Molecular weight marker proteins including BSA
(A), egg albumin (B), chymotrypsinogen A (C) and
cytochrome c (D) were used to calibrate the
Sephadex G-100 column. The available
coefficient (Kav) of the markers was found out
according to the elution profile shown in figure
2.2., Kav represents the fraction of the
stationary gel volume which is available for
diffusion of a given solute species. Kav is
calculated according to the equation Kav=(Ve-
Vo)(Vt-Vo), where Vo is the void volume, Ve is
the elution volume of a given solute species and
Vt is the volume of the packed gel bed.
temperature (20°C). Protein samples were stacked in 5% gel,
0.125M Tris-HCl, PH 6.8 and separated in 0.375M Tris-HCl,
pH 8.8. Gels were run at a constant current (20 mAgel).
Following electrophoresis, gels were stained for protein with
0.05% (wv) Coomassie brilliant blue R in a solution of 45.4%
(vv) methanol containing 9.2% (vv) acetic acid and destained
in 50% (vv) methanol containing 7.5% (vv) acetic acid.
Molecular weight standards were run for calibration purposes
( Figure 2.4). The selectivity curve was constructed
( Figure 2.5) using BSA (MW 67,000), egg albumin (MW 45,000),
aldolase (MW 40,000), chymotrypsinogen A (MW 25,000) and
cytochrome c (MW 12,500) as molecular weight standards.
2.8 Preparation of microsomal membranes
For all binding studies, the 105,000g microsomal fractions
of female rat livers or snake tissues were prepared as
described by Cheng et al. (1984), based on the original method
for pregnant rabbit liver membranes( Tsushima andv Friesen,
1973). All preparatory steps were performed at ice-cold
temperature. The snake tissues were trimmed and washed in
0.32 M sucrose. Then the tissues were weighed wet and minced.
The tissue minces were homogenized in 3 or 4 volumes of 0.32 M
sucrose using a Polytron homogenizer. The homogenate was
initially centrifuged at 10,000g for 10 minutes. The
supernatant was then subjected to ultracentrifugation at









Figure 2.4 Electrophoresis of molecular weight standards.
Molecular weight standards including
cytochrome c (MW 12,500), chymotrypsinogen A.
(MW 25,000), aldolase (MW 40,000), egg albumin
(MW 45,000) and BSA (MW 67,000) were run on
12.5% polyacrylamide gel containing 0.1% SDS at
a constant current of 20 mA. The gel was
stained for proteins with 0.05% (wv) Coomassie
brilliant blue R. Lane 2: BSA; lane 3:
chymotrypsinogen A; lane 4: aldolase; lane 5:
oPRL; lane 7: cytochrome c; lane 8: egg
albumin; lane 9: bGH; lanes 1, 6 and 10:
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Figure 2.5 Selectivity curve of SDS-polyacrylamide gel
electrophoresis.
The mobilities of the molecular weight standards
in SDS-polyacrylamide gel electrophoresis
(Figure 2.4.) were used to construct the
selectivity curve. A: BSA; B: egg albumin; C
: aldolase; D: chymotrypsinogen A; E:
cytochrome c.
pellets were suspended in 25mM Tris-HCl, pH 7.2 with
rehomogenization. The protein concentrations of the membrane
preparations were determined by the modified Folin-Lowry method
( Lowry, 1951), using crystalline BSA as standard. The
membranes were stored at -70°C in aliquots.
Rat liver microsomal membranes were prepared by similar
procedures. The liver was firstly perfused with ice-cold
0.32 M sucrose in situ to get rid of most of the blood. Then
the liver was collected. The liver mince was homogenized in 4
volumes of 0.32 M sucrose in a Teflon-pestle homogenizer( 10
strokes) and then the homogenate was subjected to the
subsequent centrifugal procedures in a similar manner as
described above. The liver microsomal membranes were also
stored at -70°C in aliquots. Appropriate amounts of frozen
membranes were thawed, diluted with 25 mM Tris-HCl, pH 7.2 to
suitable concentrations before use.
2.9 Radioiodination of hormones
The iodination of bGH and oPRL was performed at room
temperature by the modified lactoperoxidase method( Thorell
and Johansson, 1971; Cheng et al., 1984)-. To 5 ixg (5 fxl) of
the hormone in a microcentrifuge tube, 1 mCi Na125I, 20 jul
sodium acetate buffer( 0.4 M, pH 5.6), 5 fxg lactoperoxidase
in 10 [xl of the acetate buffer, and 100 ng (10 zl) of hydrogen
Peroxide were added with constant flicking. After 60 seconds
( for bGH, or 3 0 seconds for oPRL), the reaction was stopped
by addition of 0.1 ml transfer buffer( 0.01 M sodium
phosphate, 1% potassium iodide, 16% sucrose and 0.1% sodium
azide, pH 7.5), followed by 50 fil of 5% BSA. To remove
unreacted 125I and damaged hormone, the reaction mixture was
fractionated on a column (50 cm x 1 cm) of Sephadex G-100
previously equilibrated with 0.01 M sodium phosphate, 0.15 M
sodium chloride pH 7.6. Generally three radioactive peaks were
observed( Figure 2.6 and 2.7). The radioactive material that
was eluted in the void volume represented damaged and
aggregated hormone. This material was discarded because it did
hot bind to receptors when subsequently tested. The
radioactive material that was eluted from the column at a
position corresponding to the native hormone was used for all
binding studies and stored at -20°C in aliquots. The third
radioactive peak represented free 125I.
The specific radioactivity of the labelled hormone was
determined as described by Shiu and Friesen (1974). After the
iodination reaction had been stopped, 10 nl of the iodinated
mixture was taken out and diluted with 25 mM Tris-HCl, pH 7.2
containing 0.5% (wv) BSA such that 1 ml of the diluted mixture
are about 150,000 cpm. Six samples were used as a routine.
Then 2 ml of cold 10% (wv) trichloroacetic acid was added.
The tubes were mixed and then left at 4°C for 1 hour before
centrifugation at 2,000g for 20 minutes. The supernatant was
discarded and the radioactivity was assumed to represent free
125
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Figure 2.6 Iodination profile of 125I-bGH.
1 ml fractions were collected from a Sephadex
G-100 column (50cmxlcm), eluted with 10 mM
sodium phosphate, 0.15 M sodium chloride,
pH 7.6. The native 125I-bGH in fractions 34 and
35 was aliquoted and stored at -20°C for binding
assay. Fraction 46 to 52 was the free 125j-
peak. Values represented the radioactivity
counted from 5 il of each fraction.
Figure 2.7 Iodination profile of 125I-oPRL.
1 ml fractions were collected from a Sephadex
G-100 column (50cmxlcm), eluted with 10 mM
sodium phosphate, 0.15 M sodium chloride,
pH 7.6. The native 125I-oPRL in fractions 31 to
33 was aliquoted and stored at -20°C for binding
assay. Fraction 46 to 52 was the free 125j-
peak. Values represented the radioactivity
counted from 5 nl of each fraction.
hormone could thus be calculated. By knowing the amount of
hormone and Na125I used, as well as the counting efficiency,
the specific radioactivity of labelled hormones could also be
determined by obtaining the total radioactivity incorporated in
the native hormone peak from the iodination profile, but with
less accuracy. The specific radioactivity of I-labelled
hormones obtained by using the lactoperoxidase method was
generally between 60 to 120 juCijtxg for bGH and 90 to 130 Ciftg
for oPRL.
2.10 Radioreceptor assays
The 125I-oPRL and 125I-bGH binding studies were carried
out in triplicates or duplicates by methods reported previously
( Shiu and Friesen, 1974; Herington et al., 1976; Cheng et al.,
1984). The reaction mixture (0.5 ml) consisted of 0.1 ml of
Membrane preparation, 0.1 ml of 125I-labelled hormone
(100,000 cpm), and 0.1 ml of unlabelled hormone when required,
in 25 mM Tris-HCl, pH 7.2 containing 20 mM CaCl2, Q.4% (wv)
BSA.
The inclusion of calcium has been reported( Tsushima and
Friesen, 1973; Posner et cQ., 1974; Cheng et al., 1984) to
increase the binding of hormones and to allow complete
sedimentation of membrane during subsequent centrifugation of
the hormone-membrane complex. BSA was included to minimize
losses of hormone by adsorption to the tube surfaces. The
reaction mixture was incubated at room temperature (20°C) for
16 hours. The binding reaction was terminated by dilution with
3 ml of ice-cold 25 mM Tris-HCl, pH 7.2 containing 20 mM CaCl2,
0.4% BSA. Separation of bound and free hormone was achieved by
centrifugation at 5,000g for 45 minutes in a Sorvall RC5C
refrigerated centrifuge, using a HS-4 rotor. The supernatant
was decanted and the 125I-labelled hormones (oPRL or bGH) bound
to the membrane pellet was counted for radioactivity in a
Kontron Gammatic II counter with a counting efficiency of about
56%.
Total binding was measured in the absence of unlabelled
hormone and non-specific binding was taken as the 125I-oPRL or
I-bGH bound in the presence of 1 xg of unlabelled hormone.
Specific binding was obtained by subtracting the non-specific
binding from the total binding and then over that of the total
radioactivity added.
2.11 Displacement curves of 125I-oPRL and 125I-bGH binding
to female rat liver membranes
The binding of 125I-oPRL to female rat liver membranes can
be displaced by unlabelled oPRL. The ability of other
hormones to displace the binding of 125I-oPRL to female rat
liver membranes can be studied by addition of various amounts
°f the cold hormones to the reaction mixture. This is shown in
Figure 2.8( Tsim, 1984). The addition of increasing amounts
Figure 2.8 Specificity of binding of 125I-oPRL to rat liver
membranes.
Competition for binding of 125I-oPRL (expressed
as a percentage of the total 125-oPRL added per
tube) was measured in 100 ng membrane proteins,
in the oresence of i nr.rpa.si rin monnfc; nf
unlabelled hormones. oPRL
insulin
alues represent average of
triplicate determinations.
of unlabelled oPRL resulted in a gradual decrease in the
binding of the labelled tracer. 50% displacement was observed
at approximately 4 ng of unlabelled oPRL. Complete
diaplacement of the tracer was observed at 1 xg of unlabelled
hormone. HGH also competed for binding with 125I-oPRL with an
equal potency compared with oPRL. HCS also showed a similar
displacement curve but with a much diminished potency, with 50%
displacement at 60 ng of cold hormone. Non-lactogenic hormones
such as insulin, ovine GH and human chorionic gonadotropin
(hCG) did not affect the binding of 125I-oPRL even at 1 xg
concentration. The specificity of this PRL RRA was similar to
the reported results of Herington et al. (1976) and Silverstein
end Richards (1979). Only lactogenic hormones can bind to the
lactogenic binding sites, thus displacing bound 125I-oPRL from
the female rat liver membranes.
The binding specificity of 125I-bGH to female rat liver
microsomal membranes was determined by similar procedures and
the result shown in Figure 2.9. Each assay tube contained
°«3 mg of liver membrane proteins. The addition ofincreasing
amounts of unlabelled bGH resulted in a gradual decrease in the
binding of the labelled tracer. 50% displacement was observed
at approximately 22 ng of unlabelled bGH. HGH showed a higher
Potency of binding but oPRL and hCS showed a much lower
Potency. The binding specificity was comparable to the finding
°f Postel-Vinay (1976) and Hughes (1979). The somatogenic
binding sites showed high affinity for the binding of GHs,
while lactogenic hormones showed a much lower affinity of
Figure 2.9 Specificity of binding of 125I-bGH to rat liver
membranes.
Competition for binding of 125I-bGH (expressed
as a percentage of the total 125I-bGH added per
tube) was measured in 3 00 xq membrane proteins,
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2.12 Effect of protease inhibitors on the artefactua
displacement of 2I-oPRL and 2I-bGH binding t
female rat liver membranes caused by proteases
The presence of proteolytic enzymes in the reaction
mixture may degrade both the radioactive ligand and the
membranes. Figure 2.10 shows the effect of trypsin and
chymotrypsin on the binding of 125I-oPRL to female rat liver
membranes. In the presence of increasing amounts of trypsin
and chymotrypsin, the binding of the labelled tracer decreased.
The binding curve of 125I-oPRL in the presence of various
amounts of proteases was similar to the displacement curves of
unlabelled oPRL and bGH( Figures 2.8 and 2.9). This
Represents a possibility of proteases to produce a pseudo-
displacement effect in the RRA. In the presence of protease
inhibitors the artefactual effects of proteolytic enzymes can
be prevented. Figure 2.10 shows the effects of the presence of
protease inhibitors on the binding assays. The presense of
aprotinin (6.8 gml) and trypsin inhibitor (26 ju-gml) in the
Reaction mixture could prevent the actions of the proteolytic
Gnzymes trypsin and chymotrypsin.
In case of the RRAs, however, the incorporation of
aPRotinin (50 gml) and trypsin inhibitor (50 jugml) in the
Reaction mixture could not alter the binding of 125I-oPRL
Figure 2.10 Effect of proteolytic enzymes on binding of
125i_oprl to female rat liver membranes.
The binding of 125I-oPRL to female rat liver
membranes (100 g) in the presence of different
amounts of trypsin or chymotrypsin were tested
in the presence(+) or absence(-) of aprotinin
(6.8 Licrml) and trvosin inhihii-nr (0 A naml
trvpsin onlv; trune i n in fho
presence of protease inhibitors;
chymotrypsin only, chvmotrvDsin in the
presence of protease inhibitors.
( Figure 2.11) and 125I-bGH( Figure 2.12) to female rat
liver microsomal membranes. In subsequent studies aprotinin
and trypsin inhibitor were incorporated in the assay medium to
prevent artefactual displacement.
Figure 2.11 Effect of protease inhibitors on displacement
curve of 125I-oPRL binding to female rat liver
membranes.
The binding of 125I-oPRL to female rat liver
mpnihranes was determined in the oresence
or absenceof aprotinin (50 uqml) and
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Figure 2.12 Effect of protease inhibitors on displacement
curve of binding to female rat liver
membranes.
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CHAPTER 3 BINDING OF 125I-bGH AND 125I-oPRL TO SNAKE
MEMBRANES
3.1 Introduction
The development of RRA has given rise to rapid, precise
and sensitive detection of membrane receptors. Lesniack et al.
(1973) have demonstrated 125I-hGH specific binding on cultured
human lymphocytes by RRA. Tsushima and Friesen (1973) have
subsequently reported the presence of 125I-hGH specific binding
on liver membranes from pregnant rabbit. Posner et al. (1974)
have described 125I-hGH specific binding in pigeon liver and
frog kidney membranes. Since 125I-hGH can bind to both
lactogenic and somatogenic receptors( Herington et al., 1976;
Postel-Vinay, 1976), a more specific and precise RRA employing
125
I-bGH is required to study somatogenic receptors. Hung and
Moore (1984) reported specific bGH binding sites in bovine
liver membranes. Specific bGH binding sites have also been
oharacterized in non-mammalian species. Tarpey and Nicoll
(1985) have reported 125I-bGH specific binding in two fish
sPecies, Gillichthvs mirabilis and Acioenser transmontanus
( sturgeon). The binding characteristics of 125I-bGH to fish-
liver membranes were similar to those of rabbit liver
Membranes. Both membranes had highest binding affinity for bGH
ahd hGH. OPRL showed only low potency of binding. Fryer
(1979a) has demonstrated the presence of somatogenic sites in
1•
Aiver membranes from tilapia( Sarotherodon mossambicus) by a
homologous RRA. The 125I-labelled tilapia GH also showed
specific binding to liver microsomal membranes of the teleosts
Gillichvthvs misabilis. Salmo aairdneri and OncorhvnchUs
tschawvtscha but not to those of an amphibian Necturus
maculosus or to a bird Coturnix iaponica Slight but
significant specific binding was also observed with the
microsomal membranes of tilapia kidney and gill and of rat
liver.
There is more information available on the specific
binding of 125I-oPRL to tissues of various species. Turkington
(1971) first demonstrated specific binding of 125I-oPRL to mid-
••
pregnant mouse mammary tissues. Shiu et ad. (1973) have
developed a RRA for PRL binding sites on rabbit mammary gland
membranes. Posner et al. (1974) have described 125I-oPRL
specific binding in pigeon liver and frog kidney membranes.
Fryer (1979b) has developed a homologous RRA to demonstrate the
specific binding of 125I-labelled PRL in tilapia( Sarotherodon
mossambicus) kidney membranes. Edery et a_l. (1984) had
demonstrated the specific binding of 125I-oPRL to liver, ovary
and testis membranes from tilapia. The first detailed study of
125
I-oPRL specific binding in amphibian species was from White
and Nicoll (1979). They demonstrated.125I-oPRL specific
binding 'in microsomal membranes of tail, gill and kidney of the
bullfrog Rana catesbeiana and the changes of 125I-oPRL specific«.
binding in bullfrog kidney membranes during development and
Metamorphosis. White (1981) has studied the occurrence of
l25I-oPRL specific binding sites in amphibian tissues.
125I-oPRL specific binding was found in kidney and bladder
membranes. 125I-oPRL specific binding was also found in
cultured amphibian cell lines( Dunand et al., 1985), kidney
membranes from Ambvstoma tigrinum( Tarpey and Nicoll, 1987),
Rana catesbeiana( Tarpey and Nicoll, 1987), Rana esculenta
( d'Istria et a_l., 1987) and Xenopus laevis( Guardabassi
et al.. 1987). In reptiles there is only one report on the
125I-oPRL specific binding to turtle( Pseudemvs scripta
eleaans) kidney membranes( Tarpey and Nicoll, 1987). In
avians specific PRL binding sites have been found in pigeon
crop sac( Kledzik et al., 1975; Shani et al., 1977; Forysth,
1979) and ring dove( Streotooelia risoria) liver membranes
( Buntin et al., 1984).
This chapter describes the distribution and
characteristics of 125I-bGH and 125I-oPRL specific binding
sites in the tissues of the snake Ptvas mucosa.
3.2 Distribution of 125I-bGH binding sites in snak
membranes
125I-bGH specific binding to snake microsomal membranes
Was determined by RRA. Each assay tube contained 1 mg membrane
Protein except for those membrane preparations with protein
concentration lower than 10 mgml. The result is shown ina..
lable 3.1. 12 5I-bGH specific binding to snake microsomal
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able 3.1 Distribution of 125I-bGH specific binding in snake
membranes.
The specific binding of 125I-bGH to snake membranes
was determined as described in Materials and Methods.
Values shown are the means+ standard deviations (SD)
of triplicate determinations.
possessed no significant binding. Some binding was found in
membranes from snake lung, oesophagus, stomach, small intestine
and large intestine. However, the degree of specific binding
was low and non-specific binding was high.
3.3 Distribution of 125I-oPRL binding sites in snaki
membranes
125i_0pRL specific binding to snake microsomal membranes
was determined by RRA. Most membranes were assayed in a
protein content of 1 mg per tube except for those membrane
preparations with protein concentration lower than 10 mgml.
The result is shown in Table 3.2. Snake kidney membranes
showed the highest degree of 125I-oPRL specific binding and
this is true in both sexes. Snake large intestine membranes
showed a somewhat lower but still significant degree of
specific binding. Specific binding was also found in lung,
oesophagus, small intestine and testis membranes but only at
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ble 3.2 Distribution of 125I-oPRL specific binding in snake
membranes.
The specific binding of 125I-oPRL to snake membranes
was determined as described in Materials and Methods.
Values shown are the means+ SD of triplicate
determinations.
3.4 Characterization of 2®I-oPRL binding sites in snake
membranes
3.4.1 Amount of membrane protein
The binding of 125I-oPRL to snake kidney membranes
increased with increasing amount of membrane proteins added
( Figure 3.1). A similar curvilinear profile was observed for
binding to snake large intestine membranes( Figure 3.2)
except that specific binding is much lower and the extent of
non-specific binding is much higher.
3-4.2 Time and temperature dependence
The amount of 125I-oPRL bound to snake kidney membrane
increased with time and temperature of incubation. Specific
binding at 20°C reached an apparent steady state after 16 hours
°f incubation. The maximum binding observed in this experiment
20°C was about 11%. Binding at 4°C increased at a yery slow
tate( Figure 3.3) and steady state can only be reached after
an extremely long time of incubation. Specific binding of
I25
I-oPRL to snake kidney membrane increased rapidly at 37°C
( Figure 3.4), reaching a maximum of only 4% of total activity
dded and decreased after 3 hours of incubation.
The specific binding of125I-oPRL to snake large intestine
Membrane showed a similar time and temperature dependence.
SPECIFIC
NON-SPECIFIC
AMOUNT OF MEMBRANE PROTEIN PER TUBE (ng)
figure 3.1 Effect of amount of membrane protein on binding
of 125I-oPRL to snake kidney membranes.
Specific and non-specific
binding were determined as described in
Materials and Methods( Chapter 2). Values
shown are the average of duplicate
determinations and expressed as the percentage





























o 200 400 600 800 1000
AMOUNT OF MEMBRANE PROTEIN PER TUBE (mq)
Figure 3.2 Effect of amount of membrane protein on binding
of 125I-oPRL to snake larcre intestine membranes.
Specific and non-specific
binding were determined as described in
Materials and Methods. Values shown are the
average of duplicate determinations and
expressed as the percentage of the total
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Figure 3.3 Effect of incubation time on binding of
125I-oPRL to snake kidney membranes at 4°C and
2 0°C.
Specific binding was determined using 500 g
membrane protein at 4°C or 20°C as described in
Materials and Methods. Values shown are average
of duplicate determinations and expressed as the
percentage of total activity of 125I-oPRL added
per tube. 20°C 4°C
Figure 3.4 Effect of incubation time on binding of
125I-oPRL to snake kidney membranes at 37°C.
Specific binding was determined using 500 g
membrane protein at 37°C as described in
Materials and Methods. Values shown are average
of duplicate determinations and expressed as a
percentage of the total activity of 125I-oPRL
added per tube.
Specific binding at 20°C reached an apparent steady state after
16 hours of incubation( Figure 3.5). The maximum binding
observed in this experiment at 20°C was about 8.5%. Specific
binding at 4°C increased at a very slow rate. Specific binding
at 37°C increased rapidly, reaching a maximum of only 4% of
total activity added( Figure 3.6), and decreased, this time
extensively, after 3 hours of incubation.
Thus to achieve a high degree of specific binding and to
avoid excessive long hours of incubation, all subsequent assays
were carried out at 20°C for 16 hours.
3.4.3 Effect of 125I-oPRL concentration
The effect of 125I-oPRL concentration on its binding to
snake kidney microsomal membranes was determined by incubating
the membranes with increasing concentrations of I-oPRL.
Each assay tube contained 0.25 mg membrane protein. The result
was shown in Figure 3.7. Specific binding was detected at the
lowest radioactivity used( 8,300cpm) and linearly increased
thereafter up to approximately 200,000cpm. The binding did not
reach saturation up to 460,000cpm of radioactivity added.
Non-specific binding was low and increased in a linear fashion.
The specific binding of 125I-oPRL to snake kidney membrane at
different concentrations of 125I-oPRL was used for Scatchard
«
Analysis( Scatchard, 1949). Figure 3.8 shows the typical
Scatchard plot. A straight line was obtained, indicating that
Figure 3.5 Effect of incubation time on binding of
125i_oprl to snake large intestine membranes at
4°C and 20°C.
Specific binding was determined using 1500 g
membrane protein at 4°C and 20°C as described in
Materials and Methods. Values shown are average
of duplicate determinations and expressed as a
percentage of the total activity of 125I-oPRL
added per tube.
Figure 3.6 Effect of incubation time on binding of
125i_qprl to snake large intestine membranes at
37°C.
Specific binding was determined using 1500 g
membrane protein at 37°C as described in
Materials and Methods. Values shown are average
of duplicate determinations and expressed as a
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Figure 3.7 Effect of 125I-oPRL concentration on its own
binding to snake kidney membranes.
Specific and non-specific
binding were determined using 250 g membrane
protein as described in Materials and Methods.
Values shown are the average of triplicate
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figure 3.8 Scatchard plot of the binding of 125I-oPRL to
snake kidney membrane.
Scatchard analysis was carried out on data
obtained from figure 3.7 at various
concentrations of 125I-oPRL added. The binding
capacity for this particular experiment was
132 fmolmg protein and the Kd was 1.08 nM.
there is only one class of binding site, having a Kd value of
1.08 nM and a binding capacity of 132 fmolmg protein in that
particular experiment. The concentration dependence of I-
oPRL on its binding to snake kidney membrane was similar to
that of the female rat liver membrane( Figure 3.9), which
represented a Kd of 0.75 nM and a binding capacity of
180 fmolmg protein( Figure 3.10).
The concentration dependence of 125I-oPRL on its own
binding to snake large intestine membrane was shown in Figure
3.11. Specific binding increased with increasing
concentrations of 125I-oPRL added. The non-specific binding to
membrane was high. Scatchard analysis of the data gave diffuse
points, from which no significant and representative straight
line can be constructed.
3.4.4 Activation of binding by Ca2+
In the absence of Ca2+, only 8% of the added 25I-oPRL
specifically bound to the snake kidney membrane preparations
(500 [xg). Specific binding of the 125I-oPRL was increased
Markedly by the addition of Ca2+, reaching 20%. Maximal
specific binding occurred in the range of 10 to 20 mM Ca2+
( Figure 3.12). Further increases of Ca2+ concentration up to
40 mM caused a small reduction of binding. The specific
binding of 125I-oPRL to snake large intestine membrane showed
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125!-oPRL ADDED (1 04 CPMTUBE)
Figure 3.9 Effect of 125I-oPRL concentration on its own
binding to female rat liver membranes.
Specific and non-specific
binding were determined using 100 g membrane
protein as described in Materials and Methods.
Values shown are the average of triplicate
determinations and expressed as absolute counts
bound on membrane.
figure 3.10 Scatchard plot of the binding of 125I-oPRL t
female rat liver membrane.
Scatchard analysis was carried out on data
obtained from figure 3.9 at various
concentrations of 125I-oPRL added. The binding
capacity for this particular experiment was
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Figure 3.11 Effect of 125I-oPRL concentration on its own
binding to snake large intestine membranes.
Specific and non-specific
binding were determined using 1 mg membrane
protein as described in Materials and Methods.
Values shown are the average of triplicate
determinations and expressed as absolute counts
on membrane.
Figure 3.12 Effect of Ca2+ concentration on the binding of
125i_oprl to snake kidney and large intestine
membranes.
Specific binding was determined using 50cT ng of
snake kidney (SK) membrane protein or 1 mg of
snake large intestine (SLI) membrane protein,
with increasing concentrations of calcium ion
in the incubation medium, as described in
Materials and Methods. Values shown are the
average of triplicate determinations and
expressed as a percentage of the total activity
of 12I-oPRL added per tube. Snake kidnev
membrane
Figure 3.13 Effect of Ca2+ concentration on the binding of
•-2I-oPRL to female rat liver membranes.
Specific binding was determined using 100 ig of
membrane protein, with increasing
concentrations of calcium ion in the incubation
medium, as described in Materials and Methods.
Values shown are the average of triplicate
determinations and expressed as a percentage of
the total activity of 125I-oPRL added per tube.
effect of Ca2+ on the binding of 125I-oPRL to snake kidney and
large intestine membranes was similar to that of female rat
liver membrane( Figure 3.13). To achieve a high degree of
specific binding, 20 mM Ca2+ was incorporated in the standard
assays throughout the present study.
3.4.5 Effect of protease inhibitors on 125I-oPRL binding to
snake membranes
The presence of aprotinin (50 figml) and trypsin inhibitor
(50 jagml) in the assay medium caused no significant
alternations in the binding of 125I-oPRL and 125I-bGH to female
Fat liver membranes( see Chapter 2). The incorporation of
protease inhibitors in the assay medium also caused no
significant alternations on the binding of 125I-oPRL to snake
kidney and large intestine membranes( Table 3.3). This may
indicate that there were no significant proteolytic
degradations during the binding process.
34.6 Effect of p-chloromercuribenzene sulfonate treatment of
membrane on 125I-oPRL binding
Pretreatment of rat liver membrane with the thiol group
reactive agent p-chloromercuribenzene sulfonate (PCMBS) caused
an inhibition of 125I-oPRL binding( Figure 3.14). The
Pretreatment of snake kidney microsomal membrane with PCMBS had




















Table 3.3 Effect of incorporating protease inhibitors in the
assay medium on 125I-oPRL binding to snake kidney
and ladge intestine membranes.
Specific binding of 125I-oPRL to snake kidney
membranes (500 ng) and snake large intestine
membranes (1 mg) was determined in the presence of
aprotinin (50 ngml) and trypsin inhibitor
(50 gml). Rat liver membranes was also tested
for comparison-. The specific binding of 125I-oPRL
to snake membranes in the absence of the protease
inhibitors was used as control. Values shown are




























Figure 3.14 Concentration dependence of PCMBS inhibition of
125i_0PRL binding to snake kidney membranes.
The membrane (3 mg) was pretreate'd with various
concentrations of PCMBS (up to 3 mM) in a final
volume of 1.6 ml, containing 25 mM Tris-HCl,
20 mM Ca2+,- pH 7.2 at 0°C for 60 minutes. The
incubation mixture was then diluted with the
buffer to 10 ml, and centrifuged at 35,000g for
30 minutes. The pellet was washed and
centrifuged again in the same way. The pelleted
membrane was eventually resuspended in 25 mM
Tris-HCl, pH 7.2 to a concentration of 1 mgml.
Specific binding of 125I-oPRL on snake kidnev
and female rat liver memhranpR
was determined as described in Materials and
Methods. Membranes undergone the same treatment
and washing procedures in the absence of PCMBS
were used as controls. Values shown are the
average of duplicate determinations and
expressed as the percentage of control.
( Figure 3.14). PCMBS concentration up to 3 mM cannot alter
the binding of 25I-oPRL to snake membrane.
PCMBS treatment caused a marked reduction on binding of
PRL to rat liver membrane but the inhibitory effect of PCMBS on
PRL binding to snake kidney membrane was only small( Figure
3.14). Hepatic somatogenic receptor was also insensitive to
the PCMBS treatment( Tsim and Cheng, 1984). It may suggest a
difference in the molecular structure between snake renal and
rat hepatic PRL receptors. It is also possible that snake
kidney membranes have buried reactive thiol groups so that
higher concentration of PCMBS gave only lower reduction of
binding.
3.4.7 Binding specificity
The specificity of binding of 125I-oPRL to snake kidney
Membrane is shown in Figure 3.15. Addition of increasing
amounts of unlabelled oPRL resulted in a gradual decrease in
binding of 125I-oPRL. The 50% displacement was observed at
approximate 8 ng of unlabelled oPRL. HGH also competed for
binding of 125I-oPRL with slightly higher potency as compared
With oPRL. The 50% displacement was observed at about 4 ng of
bGH. HCS also showed a similar displacement curve but with a
much diminished potency, with 50% displacement at 360 ng of
labelled hormone added. BGH was also able to displace the
binding of 125I-oPRL but with a similar low potency as hCS.
Figure 3.15 Binding specificity of 125I-oPRL to snake kidney
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Figure 3.16 Binding specificity of 125j_0PRL to snake large
intestine membranes.
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125i_0PRL binding to snake large intestine
membranes were determined by adding different
amounts of the hormone to the assav medium.
Amount of cold hormone per tube
Unrelated hormones such as insulin, glucagon and hCG did not
affect the binding of 125I-oPRL even at concentration up to
1 ju-g per tube.
The binding specificity of 125I-oPRL to snake large
intestine membrane is shown in Figure 3.16. The binding of
1 p c
I-oPRL decreased gradually with the addition of increasing
amounts of unlabelled oPRL. The 50% displacement was observed
at about 8.4 ng of unlabelled oPRL. HGH also competed for the
binding to the snake large intestine membrane, with a slightly
higher potency. The 50% displacement was about 6.4 ng of
unlabelled hGH. BGH and hCS was also active in displacing the
binding of 125I-oPRL to the membrane, but with a much
diminished potency. The 50% displacement of bGH and hCS were
well above 100 ng.
3.5. Seasonal variation of 125I-oPRL specific binding to
snake membranes
The seasonal variation of 125I-oPRL specific binding to
snake membranes was determined by normal RRA on snake membranes
••
collected at different times throughout the year. The result
is shown in Table 3.4. It appears that 125I-oPRL specific
binding was generally lower in the snake kidney membranes
collected in summer as compared to those in autumn and spring.
a f
Kidney membranes from female snakes had higher degree of 125I-































Table 3.4 Seasonal variation of 125I-oPRL specific binding to
snake kidney and large intestine membranes.
Snake kidney and large intestine were collected in
different monthes throughout the year. 125I-oPRL
specific binding was determined in 500 ng of snake
kidney membrane proteins or 1 mg of snake large
intestine membrane proteins as described in
Materials and Methods. The results shown are the
means+ SD of triplicate determinations.
The seasonal variation of 125I-oPRL specific binding to
snake large intestine membranes was less pronounced as compared
to that of snake kidney membranes, except that the I-oPRL
specific binding was found to be significantly higher in the
large intestine membranes collected from prehibernating snakes
( November). No significant sex difference was observed in
the binding of 125I-oPRL to the snake large intestine membranes
collected.
There is an apparent seasonal variation in the binding of
PRL to snake kidney and large intestine. This may suggest a
change in the level of PRL receptor in the snake kidney
according to various environmental and physiological
conditions. The apparent sex difference of PRL binding to the
snake kidney may also represent a change in the level of PRL
receptor which may be under a hormonal modulation. d'Istria
al.. (1987) have reported a seasonal variation of PRL
binding to green frog kidney and skin. They showed a drop of
PRL binding in kidney in December and January and the lowest
binding was observed in June. Specific bindihg of 125I-oPRL
bo snake kidney in the winter was not determined but the low
PRL binding in snake kidney in summer is consistent with the
Result of d'Istria et al. (1987). It should be reminded that
andogenous PRL may occupy the PRL receptor and then alter the
results of the binding studies. A more precise method to study
bhe seasonal variation of PRL receptor level requires the
saturation treatment of the membrane to remove the endogenous
bound PRL( Kelly et al., 1979) but it requires large amounts
of samples. Scatchard analysis should be carried out for
comparison of the binding capacity of the membranes.
3.6 Discussion
The present study described some of the characteristics of
the binding of 125I-oPRL to microsomal membranes from the snake
kidney. Binding of 125I-oPRL to snake kidney and large
intestine membranes depended on several parameters including
time, temperature and tracer and membrane concentrations, as
has been described for interactions for I-oPRL to female rat
liver membrane( Silverstein and Richards, 1979) and turtle
kidney membrane( Tarpey and Nicoll, 1987). The binding
specificity studies( Figures 3.15 and 3.16) showed results
that were similar to that reported by Tarpey and Nicoll (1987)
in turtle kidney membrane. Both receptors showed the highest
affinity for the binding of hGH and oPRL, but much diminished
potency for hCS and bGH. However, 125I-oPRL binding to snake
kidney and large intestine membranes showed difference to the
mammalian PRL receptors. PRL receptor on female rat liver
membranes showed only minimal activity to bind non-primate GH
( Silverstein and Richards, 1979; Cheng et al., 1984)., but
snake membranes showed considerably .activity in binding of bGH.
From the saturation of snake kidney binding site by 125i-
oPRL Scatchard analysis showed the presence of one class of
binding site with a Kd value of 1.08 nM in snake kidney
membrane( Figure 3.8). The Kd values obtained from snake
kidney membranes are similar to the Kd value of the binding of
PRL to rat liver membrane( Figure 3.10), but Tarpey and
Nicoll (1987) showed a lower Kd in the binding of PRL to turtle
kidney membranes. The result corroborates the presence of PRL
receptor in snake kidney membranes. Together with other
binding characteristics reported here, the binding system of
125I-oPRL to snake kidney membrane is in general consistent
with recognized hormone-receptor interaction( Roth, 1973).
No reasonable curve can be drawn from the data of the
saturation curve of 125I-oPRL binding to snake large intestine
membranes( Figure 3.11). From the results it seems that the
presence of specific PRL binding sites in snake large intestine
is evident, but the characterization of binding is not very
successful. The main problem in the study is the high level of
non-specific binding which cannot be lowered by changing the
time or temperature of incubation. Another problem is the low
level of specific binding which is overwhelmed by the high
level of non-specific binding.
The presence of specific PRL binding site in the snake
kidney indicates that the kidney may be the target organ of the
hormone in this species, playing possibly an osmoregulatory
role. Snake larqe intestine membranes exhibit a lower but
significant PRL binding, corroborating the osmoregulatory role
of the hormone. Since the binding in snake large intestine is
relatively low, it is probably not the major site of action of
the hormone. These results in general are consistent with the
finding from another reptilian species, that oPRL can restore
plasma sodium level in hypophysectomized lizard, Dipsosaurus
dorsal is( Chan et al., 1970). The biological functions of
PRL in many lower vertebrate groups appears to be
osmoregulation( Nicoll and Bern, 1970; Bern, 1975; Loretz and
Bern, 1982). There are only limited reports on the
osmoregulatory functions of PRL in reptiles( Chan et al.,
1970; Brewer and Ensor, 1980a and 1980b). The presence of
specific PRL binding site in snake large intestine appears to
suggest a putative osmoregulatory role for PRL in reptiles.
CHAPTER- IDENTIFICATION AND PARTIAL PURIFICATION OF GROWTH
HORMONE-LIKE ACTIVITY AND PROLACTIN—LIKE ACTIVITY
FROM SNAKE PITUITARIES
4.l Introduction
PRL and GH have been purified from the pituitaries of many
mammalian and non-mammalian species. The early purification
methods employed repeated extraction and precipitation
techniques, but recent purification procedures employed more
advanced chromatographic and electrophoretic techniques.
t•
Farmer et al. (1976b and 1977) have purified GH and PRL
from the pituitaries of a tilapia Tilapia mosambica. GH and
PRL were extracted from the tilapia pituitaries by an alkaline
solution. The alkaline extract was then fractionated' on
Amberlite CG-50. Both PRL and GH were eluted with a pH 6.0
buffer. Separation of PRL and GH was achieved by subsequent
chromatography on DEAE-cellulose equilibrated with 30 mM
ammonium bicarbonate( NH4HCO3), pH 9.0. PRL was unadsorbed
( Farmer et al., 1975; and 1976b) and GH was adsorbed and
eluted with 0.2 M NH4HC03. Fractions eluted from DEAE-
cellulose chromatography were purified by a series of0
Precipitations at various pH values and salt and alcohol
concentrations. Final purification of the hormones was
cbtained by gel filtration on Sephadex G-100.
The purified tilapia GH was active in the rat tibia
bioassay and showed immunological relatedness to mammalian GH
in a rat GH RIA. The purified tilapia PRL was considerably
more potent than oPRL in the sodium-retaining bioassay in
tilapia and the reduction of water permeability in the urinary
bladder of Gillichthvs mirabilis. but it did not stimulate
mammary tissue or pigeon crop sac. The tilapia PRL also showed
activity in the rat tibia assay, and showed cross reaction in
two GH RIA( rat and snapping turtle). Tilapia GH has a
molecular weight of 22,200 daltons as determined by gel
filtration and tilapia PRL has a molecular weight of 19,400
daltons as determined by SDS-polyacrylamide gel
electrophoresis.
Separation of GH and PRL from chicken pituitaries was
achieved by Scanes et al. (1975) and Harvey and Scanes (1976).
Chicken PRL was extracted by an alkaline solution. The extract
was fractionated on Sephadex G-100. The main prolactin
fraction from the G-100 column was subjected to ion-exchange
chromatography. Chicken PRL was adsorbed by DEAE-cellulose
equilibrated with 10 mM Tris-HCl, pH 8.27 and eluted with NaCl
in the buffer giving a conductivity between 5- 10 mmho.
Chicken GH was also extracted by an alkaline solution. The GH-
containing fraction was collected between 0.2 and 0.5
saturation by addition of ammonium sulphate. The fraction was
then subjected to ion-exchange chromatography on DEAE-
cellulose. GH was unadsorbed and eluted with the equilibrating
buffer( 25 mM sodium hydroxide, 95 mM boric acid, pH 8.8).
The purified GH has a molecular weight of 23,300 daltons.
Purification of reptilian GH was reported by Farmer et a!.
(1976a). Turtle GH was firstly extracted by an alkaline
solution. The alkaline extract was then subjected to
precipitation by 0.6 saturated ammonium sulphate, followed by
ion-exchange chromatography on DEAE-cellulose. Reptilian GH
was adsorbed on DEAE-cellulose. Turtle GH was eluted from
DEAE-cellulose with 0.2 M NH4HCO3. Further purification of the
hormone was achieved by separation on Sephadex G-100
equilibrated with 50 mM NH4HCO3. Purification of PRL from the
same species was reported by Chang and Papkoff (1985). Turtle
PRL was not precipitated by saturated ammonium sulphate. The
alkaline extract was further extracted by acid acetone
solution. Turtle PRL was adsorbed on DEAE-cellulose and eluted
with 1.0 M NH4HCO3. Purified turtle PRL was active in the
pigeon crop sac assay and had a molecular weight of 22,000-
24,000 daltons.
PRL and GH have not been isolated from pituitaries of the
snake Ptvas mucosa. only Chang and Papkoff (1985) described a
partially purified snake PRL from the same genus. This' chapter
describes the partial isolation of PRL and GH from snake
pituitaries based on the method of Idler et al. (1978) who
employed chromatography on Con A-Sepharose, gel filtration and
ion-exchange chromatography on DEAE-Bio gel to achieve
Preliminary isolation of chum salmon PRL and GH. Chum salmon
PRL and GH were present in variable forms. Chum salmon GH was
adsorbed on DEAE and eluted with 2 0- 40 mM NH4HC03. Chum
salmon PRL was present in two fractions. The unadsorbed
fraction was eluted with 5 mM NH4HC03 and the adsorbed fraction
was eluted with 50- 90 mM NH4HC03.
4.2 Preparation of pituitary extrac
The snake pituitary extract was prepared by the method
described by Idler et al. (1978). All the procedures were
performed at ice-cold temperature. To 8.81 g of snake
pituitaries( about 1,000 pituitaries), 50 ml of buffer B(
50 mM Tris-HCl, pH 7.8, containing 1 mM CaCl2, 1 mM MgCl2,
0.5 M NaCl and 0.2 mM dithiothreitol) containing 15 jugml of
aprotinin was added. The mixture was homogenized and the
homogenate was centrifuged at 20,000g at a Beckman J2-21
centrifuge for 25 minutes. The supernatant was collected 'and
the pellet was re-extracted by 50 ml of the above buffer again.
The mixture was centrifuged at 20,000g again for 25 minutes.
The supernatant was collected and pooled. The pooled
supernatant was then filtered through 4 layers of cheesecloth.
From a start of 8.81 g of pituitaries, 99 ml of pituitary
extract was prepared which represented a protein cohtent of
958.32 mg as determined by the Lowry's method (1951).
4.3 Fractionation of snake pituitary extract on
Con A-Sepharose
Snake pituitary extract was applied on a Con A-Sepharose
affinity column and eluted with buffer B. The non-
glycoproteins were unadsorbed and the glycoproteins were eluted
with 1 M a-methyl-D-glucoside in buffer B. The elution profile
was shown in Figure 4.1. The unadsorbed non-glycoprotein
fraction was called ConA I and the adsorbed glycoprotein
fraction was called ConA II. The ConA I fraction was collected
and concentrated by ultrafiltration using a Diaflo PM-10
membrane (MW cut off= 8,000 daltons). The Con A-Sepharose
column was regenerated by extensive washing of carbohydrate-
free buffer B and the ConA I fraction was rechromatographed on
the Con A-Sepharose column again. The elution profile was
shown in Figure 4.2 which had a much smaller peak of ConA II
after elution with buffer B containing 1 M a-methyl-D-
glucoside. This indicated the ConA I fraction was not
contaminated by the ConA II fraction. Both ConA I and ConA II
fractions were collected and pooled. The combined ConA I and
ConA II fractions were dialyzed against distilled water, then
lyophilized. From 8.81 g of pituitaries, 883.7 mg of ConA I
and 404.5 mg of ConA II were collected.
The abilities of snake pituitary extract, ConA I and
ConA II to displace 125I-oPRL from binding to female rat liver
membranes were tested by PRL RRA. When PRL RRA and bGH RRA
wore carried out to determine the presence of PLA and GHLA,
Figure 4.1 Affinity chromatography of an extract of 8.81 q
cnaVo nifnifariPd nn Pnn A-Spnharnsp.
Column dimension: 37 cm x 1.35 cm. Flow rat
: 20 mlh. Fraction size: 5.5 ml. Startin
buffer: 50 mM Tris-HCl, pH 7.8, containing 1 ml
CaCl2, 1 mM MgCl2, 0.5 M NaCl and 0.2 ml
dithiothreitol. The arrow indicates the point
of application of 1.0 M of a-methyl-D-glucosidein the starting buffer
Fraction No.
Figure 4.2 Re-chromatography of fraction ConA I on Con A-
Seoharose.
Column dimension: 37 cm x 1.35 cm. Flow rate
: 13 mlh. Fraction size: 7.3 ml. Starting
buffer: 50 mM Tris-HCl, pH 7.8, containing 1 mM
CaCl2, 1 mM MgCl2, 0.5 M NaCl and 0.2 mM
dithiothreitol. The arrow indicates the point
of application of 1.0 M of a-methyl-D-glucoside
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aprotinin (50 gml) and trypsin inhibitor (50 jagml) were
incorporated in the assay medium to prevent artefactual
displacement effect caused by degradation. This decreased the
possibility of tracing a proteolytic enzyme in the separation
process. The result was shown in Figure 4.3. Both curves
showed displacement effect on the binding of 125I-oPRL to rat
liver membranes. The potency of ConA I was slightly higher
than that of snake pituitary extract but the ConA II fraction
had a much lower potency as compared to the snake pituitary
extract and ConA I. Figure 4.4 shows the displacement curves
of the snake pituitary extract, ConA I and ConA II in bGH RRA.
The assay medium contained protease inhibitors to prevent
degradation. Both curves were able to displace 125I-bGH from
binding to the rat liver membranes. ConA I had the highest
potency and the potency of the pituitary extract was slightly
lower. The potency of ConA II was substantially lower.
The abilities of pituitary extract to displace 125I-oPRL
and 125I-bGH from binding to female rat liver membranes
indicated the presence of PLA and GHLA in snake pituitary
extract which were mainly concentrated in the ConA I fraction
after separation by the Con A-Sepharose column. The result
indicated that both PLA and GHLA in snake pituitaries are non-
glycoproteins.
Figure 4.3 Displacement curves of snake pituitary extract,
fraction ConA I and fraction ConA II on bindinc
of 125I-oPRL to female rat liver membranes.
The presence of PLA was detected by its ability
to displace 125I-oPRL binding to female rat
liver- -membranes. Different amounts of snake
pituitary extract fra n.t i nn Pnn A T
or fraction ConA II were
incorporated in the assay medium to test for the
presence of PLA. The assay medium contained
aprotinin (50gml) and trypsin inhibitor







































0.1 ng 1 ng 10ng 100ng 1 n9 10 yi2 100n9
Amount of hormoneprotein per tube
Figure 4.4 Displacement curves of snake pituitary extract,
fraction ConA I and fraction ConA II on binding
of 125I-bGH to female rat liver membranes.
The presence of GHLA was detected by its
ability to displace 125I-bGH binding to female
rat liver membranes in the presence of protease
inhibitors. Different amounts of snake
pituitary extract
-fy~z i rn Pnn A T
or fraction ConA II were
incorporated in the assay medium to test for the
presence of GHLA.
Amount of hormoneprotein per tube
4.4 Fractionation of ConA I on Sephadex G-100
The GHLA-containing and PLA-containing ConA I fraction was
applied on a Sephadex G-100 column. Figure 4.5 shows the
elution profile. The ConA I was separated into five peaks.
Peak I( fraction I) was the void volume peak and the
subsequent peaks were named as fractions II to V respectively.
The presence of GHLA was monitored by bGH RRA in an assay
medium containing protease inhibitors to prevent artefactual
displacement caused by degradation. GHLA was found to be
present in all the fractions. Figure 4.6 showed the
displacement curves of the fractions. All of them to different
extents were able to compete for the binding of 125I-bGH to rat
liver membranes. Fraction III exhibited the highest potency
and fraction V had the lowest potency. Figure 4.7 showed the
displacement curves of the fractions in displacing 125I-oPRL
from binding to rat liver membranes. The PLA was found to be
concentrated mostly in fraction III which exhibited the highest
Potency in the assay. Fractions II and IV were only partially
active whereas fractions I and V had no activity at all.
After gel filtration fractions I to V were analysed by
sDS-polyacrylamide gel electrophoresis. In 10% gel ConA I and
fraction I were heterogeneous. There were many bands
throughout the whole length of the gel( Figure 4.8).
fraction II also showed multiple bands. There were many faint
hands on the gel corresponding to the molecular weights between
Figure 4.5 Gel filtration of 110 mg fraction ConA I on
Sephadex G-100.
Column dimension: 73 cm x 2.3 cm. Flow rate:
13 mlh. Fraction size: 6.7 ml. Buffer:
50 mM NH4HCO3. Recovery: fraction I 23.1 mg;
fraction II 30.9 mg; fraction III 8.3 mg;
fraction IV 3.6 mg; fraction V 22.7 mg.
Figure 4.6 Effects of gel filtration fractions on bindin
of 125I-bGH to female rat liver membranes.
The presence of GHLA in gel filtration
fractions was detected by their ability tc
displace 125I-bGH binding to female rat liver
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Figure 4.7 Effects of gel filtration fractions on binding
of 125I-oPRL to female rat liver membranes.
The presence of PLA in gel filtration fractions
was detected by their ability to displace
125i_qprl binding to female rat liver membranes
in the oresence of orotease inhibitors.
Different amounts of oPRL fractions II
III and IV were
incorporated in the assay medium to test for the
presence of PLA. Fractions I and V showed no
activity in the assay.






Figure 4.8 Electrophoresis of gel filtration fractions.
Fractions I ..to V were run on 10% polyacrylamide
gel containing 0.1% (wv) SDS at constant
current of 20 mA and stained for proteins with
0.05% Coomassie brilliant blue R as described in
Materials and Methods. Lanes 1, 6 and 11:
molecular weight standards; lane 2: fraction
ConA I; lane 3: fraction I; lane 4:
fraction II; lane 5: oPRL; lane 7:
fraction III; lane 8: bGH; lane 9: fraction
IV; lane 10: fraction V.
25,000 to 70,000 daltons. Fraction III which showed distinct
activity in PRL RRA possessed the less contamination with high
molecular weight bands. There were still many faint bands on
the gel corresponding to a molecular weight of about 25,000
daltons. There were two intense bands corresponding to lower
molecular weights. Fractions IV and V showed only faint bands
and no high molecular weight bands were observed.
Most of the GHLA and PLA were recovered from fraction III
after gel filtration of ConA I. Fraction III showed the
highest activity in the PRL RRA and bGH RRA. Fraction III
corresponded to a molecular weight of about 24,000 daltons.
The presence of PLA in the fraction was consistent with the
molecular weight of other purified non-mammalian PRLs( Scanes,
1975; Farmer et al., 1977; Chang and Papkoff, 1985; Yamamoto
et al., 1986). GHLA was present in all the fractions.
Fraction III showed the highest activity in the bGH RRA. The
result was also consistent with other purified non-mammalian
GHs( Farmer et al., 1976a; 1976b; Harvey and Scanes; 1976)
because GH was also a small protein with a molecular weight
similar to that of PRL. Gel filtration cannot separate GHLA
and PLA because they have similar molecular weights( 19,000-
25,000 daltons). GHLA was present in all the fractions
including the void volume peak and the low molecular weight
fractions. It may indicate the presence of high molecular
Weight forms of GHLA, or the high molecular weight precursors
of the molecule, or aggregation of the GHLA. The presence of
GHLA in low molecular weight fractions may be caused by the
degraded fragments of GHLA which retain some activity of GHLA.
However, significant PLA was only found in fraction III after
gel filtration. The result suggests the presence of PLA with
low molecular weight( about 20,000 daltons) and also the
presence of GHLA in the same fraction but with more
heterogeneity.
In SDS-polyacrylamide gel electrophoresis fraction III
showed multiple bands( Figure 4.8). The two low molecular
weight bands were very close and it would be very difficult to
be separate them by virture of their difference in molecular
weights. Further purification of fraction III is possible but
a large amount of sample is required. It is possible to use
high resolution separation techniques like ion-exchange
chromatography on DEAE-cellulose or CM-cellulose but it
requires a large amount of samples because of the non-specific
adsorption on ion-exchange columns. Instead, ion-exchange
chromatography of ConA I was preferred as described in the
following section.
4.5 Ion-exchange chromatography of fraction ConA I on
DEAE-cellulose
The snake pituitary ConA I fraction was applied on a DEAE-
cellulose column( 13 cm x 0.9 cm) equilibrated with 10 mM
NH4HC03, pH 9.0. Unadsorbed proteins were eluted with the
equilibrating buffer. Adsorbed proteins were eluted with
increasing concentrations of the buffer. Figure 4.9 shows the
elution profile. ConA I was separated into several peaks after
ion-exchange chromatography on DEAE-cellulose. There were one
large unadsorbed peak( fraction A) and two large adsorbed
protein peaks. The first adsorbed peak( fractions H and I)
was eluted with 0.2- 0.35 M of the NH4HCO3 buffer and the
second one( fraction L) was eluted with higher concentration
of the buffer( 0.5 M). There were also other small peaks.
The fractions were collected and pooled according to the
profile, then lyophilized.
The presence of GHLA in the fractions was detected by
their abilities to displace 125I-bGH from binding to rat liver
membranes. Fraction B showed the highest potency for the
displacement of 125I-bGH binding( Figure 4.10 and 4.11), but
the amount collected was small (0.8 mg). Fraction A which
exhibited a lower potency for the displacement of 125I-bGH
binding to rat liver membranes was present ina larger quantity
(35.4 mg). Fraction C which was as potent as fraction A was
present in small amount (3.6 mg).
Figure 4.12 showed the displacement curves of the
fractions on the binding of 125I-oPRL to rat liver membranes.
°nly fractions H and I showed displacement effect on the
binding of 125I-oPRL to rat liver membranes. Other fractions
bad no activity. Fractions H and I were also tested for their
abilities to displace 125i-oPRL from binding to snake kidney
Membranes. All the fractions tested showed lower potencies as
Figure 4.9 Ion-exchange chromatography of 62 mg fractio]
ConA I on DEAE cellulose.
Column dimension: 13 cm x 0.9 cm. Flow rate:
12 mlh. Fraction size: 3.2 ml. Starting
buffer: 10 mM NH4HCO3, pH 9.0. Recovery:
fraction A 35.4 mg, fraction B 0.8 mg,
fraction C 3.6 mg, fraction D 46.7 mg,
fraction E 0.6 mg, fraction F 1.1 mg, fraction G
3.4 mg, fraction H 2.4 mg, fraction I 10.9 mg,
fraction J 1 mg, fraction K 3 mg, fraction L
4.1 mg, fraction M 0.4 mg, fraction N 3 mg,
fraction O 67.8 mg.
Fraction No.
Figure 4.10 Effects of DEAE fractions on binding of
125i_bGH to female rat liver membranes.
The presence of GHLA in DEAE fractions was
detected by their ability to displace 125I-bGH
binding to female rat liver membranes in the
presence of protease inhibitors. Different
amounts of bGH frantinns£
H T T, TuT
and N wprp innnrnnrahpH in thp
assay medium to test for the presence of GHLA
Amount of hormoneprotein per tube
Figure 4.11 Effects of DEAE fractions on binding of
125t —bGH to female rat liver membranes.
The presence of GHLA in DEAE fractions was
detected by their ability to displace 125I-bGH
binding to female rat liver membranes in the
presence of protease inhibitors. Different
amounts of bGH franfions£
were incorporated in the assav medium to
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Figure 4.12 Effects of DEAE fractions on binding of
125i_0pRL to female rat liver membranes.
The presence of PLA in DEAE fractions was
detected by their ability to displace 125I-oPRL
binding to female rat liver membranes in the
presence of protease inhibitors. Different
amounts of oPRI fractions A tr
I and L wprp
incorporated in the assay medium to test for the
presence of PLA. Other fractions showed only
low activity in the assay.
Amount of hormononrotoin nor tnho
compared to the potency of bGH. Among the fractions studied,
fraction H showed the highest potency in the assay. Fraction I
had a slightly lower potency but it was still higher than the
potency of fraction ConA I. Fraction A had very low activity
in the assay( Figure 4.13). The result suggests the presence
of PLA in fractions H and I.
Separation of snake GHLA from snake PLA was achieved by
ion-exchange chromatography on DEAE-cellulose. Snake GHLA
( fraction All) was unadsorbed on DEAE cellulose while snake
PLA( fraction H'll) was adsorbed. The result was comparable
to the purification of PRL and GH from chicken pituitaries
( Scanes et al., 1975; Harvey and Scanes, 1977). Chicken GH
was unadsorbed on DEAE-cellulose while chicken PRL was
adsorbed. The purifications of turtle PRL and GH were also
similar. Both turtle GH and PRL were adsorbed to DEAE--
cellulose. Turtle GH was eluted with lower concentration of
buffer while the elution of turtle PRL required 1.0 M of
NH4HCC3( Farmer et aJL., 1976a; Chang and Papkoff, 1985). The
purifications of GH and PRL from tilapia pituitaries were
different. Tilapia PRL was unadsorbed on DEAE-cellulose while
tilapia GH was adsorbed( Farmer et al., 1976b and 1977).• The
result may suggest that the partially purified snake GHLA and
PLA are closer to purified PRL and GH from chicken and turtle
pituitaries.
Figure 4.13 Effects of DEAE fractions on binding of
125i_oPRL to snake kidney membranes.
The presence of PLA in DEAE fractions was
detected by their ability to displace 125I-oPRL
binding to snake kidney membranes
( 400 ugtube )in the presence of protease
inhibitors. Different amounts of oPRL(
fractions A
and fraction ConA I were
incorporated in the assay medium to test for the
presence of PLA.
Amount of hormoneprotein per tube
Snake GHLA is unadsorbed to DEAE-cellulose at pH 9.0 while
snake PLA is adsorbed. DEAE-cellulose is an anion exchanger
which carries positive charges at pH 9.0. The result indicates
that snake PLA carries negative charges while snake GHLA
carries positive charges at pH 9.0. Snake GHLA may have a pi
value higher than pH 9.0 while snake PLA may have a pi value
lower than pH 9.0.
After ion-exchange chromatography on DEAE-cellulose GHLA
was present in many fractions including the unadsorbed and
adsorbed fractions. The result may suggest the presence of
variable forms of GHLA in snake pituitaries. Apparently ion-
exchange chromatography of fraction ConA I on DEAE-cellulose
was able to separate GHLA from PLA. Fraction A possessed only
GHLA with high potency and no PLA. Only fractions H and I
among others exhibited PLA. The result suggested a possibility
to isolate GHLA from PLA which can then undergo subsequent
separation processes to identify GHLA and PLA.
4.6 Electrophoretic analysis of snake pituitary fractions
After ion-exchange chromatography on DEAE-cellulose,' the
unadsorbed protein peak( fraction A) showed high potency in
the bGH RRA but no activity in the PRL RRA. However, only
fractions H and I showed activities in the PRL RRA. This
indicated that fraction A contained GHLA and fractions H and I
contained PLA with some GHLA contamination. The fractions( A,
H and I) were then analysed by SDS-polyacrylamide gel
electrophoresis.
In 10% gel fractions H and I showed similar
electrophoretic patterns and fraction A showed a different one
( Figure 4.14). Fractions H and I were heterogeneous. There
were many electrophoretic bands throughout the whole length of
the gel. There were many high molecular weight bands but the
low molecular weight bands were more intense. Fractions H and
I had many common bands. The most intense band of fraction I
corresponded to a molecular weight of 16,000 daltons if
compared to the molecular weight standards( Figure 4.15).
Fraction A contained less bands. It contained only a minute
amount of high molecular weight bands. There were only two
distinct and intense bands. The most intense one was fast-
moving and exhibited a molecular weight of 12,500 daltons.'
Another distinct band was also fast-moving and exhibited a
molecular weight of 19,000. The snake pituitary ConA I
fraction was also run on the same gel. The ConA I fraction
contained many bands throughout the whole length of the gel.
There was a distinct and intense band which corresponded to the
molecular weight 19,000 daltons band of fraction A. In another
run the fractions A, H and I were analysed in a 12.5% gel.
The results were similar( Figure 4.16). Fractions H and I
were very heterogeneous and possessed many common bands.
Fraction A had two distinct bands, one corresponded to a
molecular weight of 12,500 daltons and the other corresponded







Figure 4.14 Electrophoresis of fractions A, H, I and
fraction ConA I.
Fractions A, H, I and fraction ConA 1 Were run
on 10% polyacrylamide gel containing 0.1% (wv)
SDS at constant current of 20 mA and stained for
proteins with 0.05% Coomassie brilliant blue R
as described in Materials and Methods. Lanes
1, 6 and 18: oPRL; lanes 2 and 10: fraction H;
lanes 3 and 14: fraction ConA I; lanes 4 and 15
: molecular weight standards; lane 5:
chymotrypsinogen A; lane 7: BSA; lane 8:
fraction I; lanes 9 and 16: aldolase; lane 11:
























Figure 4.16 Electrophoresis of fractions A, H and I.
Fractions A, H and I were run on 12.5%
polyacrylamide gel containing 0.1% (wv) SDS at
constant current of 20 mA and stained for
proteins with 0.05% Coomassie brilliant blue R
as described in Materials and Methods. Lane 1:
BSA; lanes 2 and 13: bGH; lanes 3 and 14:
oPRL; lanes 4, 8 and 12: molecular weight
standards; lanes 5 and 9: fraction I; lanes 6,
10 and 15: fraction H; lanes 7 and 11
fraction A.
Molecular weight
Figure 4.17 Molecular weights of fraction A.
The mobilities of the major bands of fractions.
A( Figure 4.16.) were compared to the
selectivity curve constructed from the
mobilities of the molecular weight standards
( close circles). Fraction A showed two
distinct bands corresponding to molecular
weights of 19,500 daltons( point 2) and 12,500
daltons( point 1).
4.7 Separation of fraction A on Sephadex G-50
After ion-exchange chromatography of fraction ConA I on
DEAE-cellulose the unadsorbed protein peak( fraction A)
possessed most of the GHLA but no PLA. Fraction A also showed
two distinct bands in SDS-polyacrylamide gel electrophoresis.
The two bands were separate, one having a molecular weight of
12,500 daltons and the other 19,000 daltons. This suggested a
possibility to separate the two bands by their difference in
molecular weight.
Fraction A was applied on a Sephadex G-50 (MW cut
off= 30,000) column. Figure 4.18 shows the elution profile.
There was one large peak in the void volume position associated
with some tailing. The void volume peak was named fraction AI.
The tailing part of the void volume peak was collected
separately and named as fraction All. Fraction AIII was the
later part of the profile which consisted of a small and broad
peak.
The ability of the fractions to displace bound 125I-bGH
from rat liver membranes was determined by bGH RRA. Figure
4.19 showed the effects of fractions AI, All and AIII on the
binding of 125I-bGH to rat liver membranes. Both fractions AI
and All were able to displace the binding of 125I-bGH to rat
liver membranes. Fraction All had the highest potency but
fraction AI was only partially active. Fraction AIII had no
detectable activity in the bGH RRA, In another assay fraction
FRACTION NO.
Figure 4.18 Gel filtration of 10 mg fraction A on Sephadex
G-50.
Column dimension: 72.4 cm x 0.95 cm. Flow
rate: 15 mlh. Fraction size: 1.5 ml. Buffer
: 50 mM NH4HCO3. Recovery: fraction AI
310 ng; fraction All 650 ng; fraction AIII
61.2 mg.
Figure 4.19 Effects of fractions AI, All and AIII on
binding of l25i-bGH to female rat liver
mbmhrnpc_
The presence of GHLA in A-derived fractions was
detected by their ability to displace 125I-bGH
binding to female rat liver membranes in the
presence of protease inhibitors. Different
amniints of hGH frart-inns AT
All and AIII
• I
in the assay medium to test for the presence of
GHLA.
Amount of hormoneprotein per tube
All was shown to be more potent than fraction A in the bGH RRA,
but the difference was only very small( Figure 4.20).
In SDS-polyacrylamide gel electrophoresis, fraction AI was
still heterogeneous. There were many bands observed( Figure
4.21). Fraction All was relatively pure. There was one
significant band observed with very little contamination by
high molecular weight bands. The major band had a mobility
between those of bGH and oPRL corresponding to a molecular
weight of 18,750 daltons by comparing to the mobilities of the
molecular weight standards( Figure 4.22).
4.8 Separation of fractions H and I on Sephadex G-50
After ion-exchange chromatography on DEAE-cellulose,
fractions H and I were the only fractions which contained PLA.
In SDS-polyacrylamide gel electrophoresis fractions H and I
were heterogeneous. They had many bands throughout the whole
length of the gel. Since there was only a very small amount of
fraction H( 2.4 mg) collected, the two fractions were
therefore combined to undergo the subsequent isolation steps.
The combined fraction was named as fraction H'.
Fraction H' was applied on a Sephadex G-50 column. The
slution profile was shown in Figure 4.23. There were one large
void volume peak( fraction H'l) and two smaller peaks
( fractions H'll and H'lII) followed subsequently. The
Figure 4.20 Effects of fractions A and All on binding of
125I-bGH to female rat liver membranes.
Fractions A and All were tested for their
ability to displace 125I-bGH binding to female
rat liver membranes. Different amounts of bGH
fractions A and ATI
were incorporated in the assay medium to test
for their potency in displacing 125I-bGH binding
to female rat liver membranes.
Amount of hormoneprotein per tube
Figure 4.21 Electrophoresis of fractions AI and AI]
Fractions AI and All were run on 10
polyacrylamide gel containing 0.1% (wv) SDS a1
constant current of 20 mA and stained foi
proteins with 0.05% Coomassie brilliant blue I
as described in Materials and Methods. Lane 1
bGH; lane 2: fraction All; lane 3: molecula]
weight standards; lane 4: fraction AI; lane 5
oprl
10,000 20 000 40.0%30 80,000
Molecular weight
Figure 4.22 Molecular weight of fraction All
The mobility of the major band of fraction All
( Figure 4.21.) was compared to the selectivity
curve constructed from the mobilities of the
molecular weight standards( close circles).
Fraction All showed a distinct band
corresponding to a molecular weights of 18,750
daltons( open circle).
Fraction No.
Figure 4.23 Gel filtration of 10 mg fraction H' on Sephadex
G-50.
Column dimension: 72.4 cm x 0.95 cm. Flow
rate: 11.2 mlh. Fraction size: 1.8 ml.
Buffer: 50 mM NH4HCO3. Recovery: fraction
H11 3.9 mg; fraction H'll 2'. 2 mg; fraction H'lII
2.2 mg; fraction H'lV 0.750 mg.
fractions were collected and pooled according to the elution
profile, then lyophilized.
The presence of PLA in the fractions was determined by PRL
RRA in the presence of protease inhibitors. Among these
fractions H'll had the highest potency in the assay. The
original fraction H' had a lower potency as compared to
fraction H'll but had a higher potency when compared to the
other H'-derived fractions( Figure 4.24). This indicated an
increase in the purification of PLA. Fraction All was inactive
in the PRL RRA.
In the bGH RRA( Figure 4.25) H'-derived fractions and
fraction H' showed only low activity. Fraction All showed the
highest potency. It was noteworthy that fraction H'll showed a
lower potency in bGH RRA as compared to that of fractions H'..
and H'l. This indicated that fraction H'll is a PLA enriched
fraction.
After gel filtration on Sephadex G-50 the fractions were
subjected to SDS-polyacrylamide gel electrophoresis. In 12.5%
gel fractions H' and H'l were heterogeneous. There were many
bands throughout the whole length of the gel( Figure 4.2 6).
In fraction H' there was one intense band which corresponded to
a molecular weight of 16,000 daltons( Figure 4.27). Fraction
H'.n contained less high molecular weight bands. Only very
faint bands were observed in the high molecular weight range.
One distinct and intense band corresponding to a molecular
Figure 4.24 Effects of Sephadex G-50 fractions on binding
of 125I-oPRL to female rat liver membranes.
The presence of PLA in various fractions after
gel filtration of fraction H' on Sephadex G-50
was detected by their ability to displace
125i_qprl binding to female rat liver membranes
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Figure 4.25 Effects of Sephadex G-50 fractions on binding of
125i_foGH to female rat liver membranes.
The presence of PLA in various fractions after
gel filtration of fractions A and H' on
Sephadex G-50 was detected by their ability to
displace 125I-bGH binding to female rat liver
membranes in the presence of protease
inhibitors. Different amounts of bGH
fractions H' H' I H' IT
H' III H• IV A and
fraction All were incorporated in the
assay medium to test for the presence of PLA.
Amount of hormoneprotein per tube
Figure 4.26 Electrophoresis of H'-derived« fractions and
fraction ATT.
H'-derived fractions and fraction All were run
on 12.5% polyacrylamide gel containing 0.1%
(wv) SDS at constant current of 20 mA and
stained for proteins with 0.05% Coomassie
brilliant blue R as described in Materials and
Methods. Lanes 1, 6 and 11: molecular weight
standards; lane 2: fraction H'lV; lane 3:
fraction H'lII; lane 4: fraction H'; lane 5:
fraction H'l; lane 7: fraction H'll; lane 8:
oPRL; lane 9: fraction All; lane 10; bGH.
Figure 4.27 Molecular weights of fractions. All, H'll and
H'lII.
The mobilities of the major bands of fractions
All, H' 11 and H'lII( Figure 4.26.) were
compared to the selectivity curve constructed
from the mobilities of the molecular weight
standards( close circles). Fraction All
showed a distinct band corresponding to a
molecular weights of 20,000 daltons( point 3).
The major band of fraction H'lII corresponded to
a molecular weight of 18,250 daltons( point
2), and the major band of fraction H'll
corresponded to a molecular weight of 16,000
daltons( point 1).
weight of 16,000 daltons was observed. Fraction H'lII
contained an intense band which corresponded to a molecular
weight of 18,250 daltons. It contained less high molecular
weight bands but many low molecular weight bands. Fraction
H'lV contained only a very faint band which corresponded to a
low molecular weight.
4.9 Characterization of fractions All and H1!!
4.9.1 Electrophoretic analysis of fractions All and H1!!
After ion-exchange chromatography on DEAE cellulose the
GHLA-containing and PLA-containing fractions were subjected to
gel filtration on Sephadex G-50 which has a molecular weight
cut off value of 30,000 daltons. As a result, the GHLA and PLA
were eluted out following the void volume peak. The
corresponding fractions were collected and analysed by SDS-
polyacrylamide gel electrophoresis.
Fraction All and fraction H'll were analysed by SDS-
polyacrylamide gel electrophoresis( Figure 4.26). Fraction
All showed a distinct band which corresponded to a molecular
weight of 20,000 daltons( Figure 4.27)• It contained some
faint and broad bands in the low molecular weight range but no
high molecular weight bands. Fraction H'll showed an intense
and distinct band which corresponded to a molecular weight of
16,000 daltons( Figure 4.27). Fraction H'll also showed many
other bands but there were more intense bands in the low
molecular weight range.
In SDS-polyacrylamide gel electrophoresis both fractions
All and H'll showed multiple bands. Fraction All was
relatively pure. Major contaminations came from the faint
bands observed in the low molecular weight range( Figure
4.26). A more precise method of the confirmation of the
purity of the protein is electrophoresis of the fraction in
absence of SDS and reducing agents in both acidic and alkaline
pH values. Fraction H'll showed lower purity. There were many
faint bands in the high molecular weight range and also a smear
of faint bands in the low molecular weight range, indicating
the contamination of both high and low molecular weight
components( Figure 4.26).
The major band of fraction All has a molecular weight of
about 20,000 daltons. Fraction H'll has a lower molecular
weight (16,000 daltons). Farmer et aJL. (1976b and 1977) have
also reported a higher molecular weight in purified tilapia GH
4'
while PRL had a lower molecular weight. Moreover, the
molecular weights of the partially purified snake GHLA and PLA
are relatively lower as compared to the molecular weights of
other purified GH and PRL. This may mean that the snake GHLA
and PLA are actually lower in molecular weights, or degraded
forms of GHLA and PLA may be present in fractions All and H'll.
However, the electrophoretic bands corresponding to molecular
Weights of 20,000 and 16,000 daltons are also present in
fraction ConA I( Figure 4.14) This lends support to the
notion that snake GHLA and PLA are actually lower in molecular
weight, unless the occurrence of degradation happens very early
in the purification steps.
4.9.2 Displacement curves of fractions All and H'll
on 125I-bGH binding to female rat liver membranes
The A-derived and H'-derived fractions were tested for
their abilities to displace 125I-bGH binding to female rat
liver membranes. The results were shown in figure 4.28.
Fraction A and All showed higher potencies for the
displacement of 125I-bGH binding as compared to the potencies
of fraction H' and H'-derived fractions. Fractions H'lII and
H'lV were nearly inactive in the assay. Fraction H'l was more
active than H'll in displacing 125I-bGH binding to female rat.,
liver membranes and fraction H'll showed a lower potency in the
assay as compared to the potencies of fractions H' and H'l.
4.9.3 Displacement curves of fractions All and H'll
1? 5
on I-oPRL binding to female rat liver membranes
H'-derived fractions and the partially purified GHLA were
tested for their abilities to displace 125I-oPRL binding to
female rat liver membranes. Fraction H'll showed the highest
potency in the assay. The potency of H' in displacing 125i-
oPRL binding was lower than that of fraction H'll but it was
Figure 4.28 Effects of A-derived and H'-derived fractions
on binding of 12I-bGH to female rat liver
mpmhranpc:_
Fractions A, All, H', H'l, H'll, H'HI and H'lV
were tested for their ability to displace
125t-V»CW hinHirrr +-o fpina 1 r~+- 1 ivpr mpmhranpc;_
Different amounts of bGH fyapfinnc A
All H' T-T» T
H'll H' III and H» TV
were incorporated in the assay medium to test
for their potency in displacing 125I-bGH binding
to female rat liver membranes.
Amount of hormoneprotein per tube
higher than the potency of fraction H'l. Fraction H'lII showed
only minimal activity and fraction All was inactive in the
assay( Figure 4.29).
4.9.4 Displacement curves of fractions All and H1!! on
125I-oPRL binding to snake kidney membranes
Specific binding sites for 125I-oPRL were present in
snake kidney microsomal membranes( see Chapter 3). Fractions
All and H'll were tested for their abilities to displace 125i-
oPRL binding to snake kidney membranes. All of the fractions
had lower potencies as compared to oPRL and bGH. Fraction H'll
had the highest potency in the assay and the potency of
fraction H' was slightly lower( Figure 4.30). Fraction
ConA I had only low potency in the assay and fractions A and
All had minimal activity in the assay.
4.9.5 Displacement curves of fractions All and H'll on
125I-oPRL binding to snake large intestine membranes
Specific binding sites for 125I-oPRL were present in snake
large intestine microsomal membranes( see Chapter 3.).
Fractions All and H'll were tested for their abilities to
displace 125I-oPRL binding to snake large intestine membranes.
All the fractions tested were only partially active and had
lower potencies as compared to oPRL and bGH. Among the
fractions tested, fraction H'll was seemingly the most active
Figure 4.29 Effects of A-derived and H'-derived fractions
on binding of 125I-oPRL to female rat live]
membranes.
Fractions A, All, H', H'l, H'll, H'HI and H'lV
were tested for their ability to displace
12 5 T— aTDT? T Ki -i nrf 4-o F am al o v-a+- 1
Di ffp.rp.nt: amounts of nPRT
VCJL lUCZlUUJL Cll ICO«
— . • _ « _ _
H 1 U t T
TT I T- T
and H'll
— f— w w r v
xjoro i nrnrnnraforl in fhc
medium to test for their potency in displacing
125i_oprl binding to female rat liver membranes.
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Figure 4.30 Effects of A-derived and H'-derived fractions
on binding of 125I-oPRL to snake kidney
membranes.
Fractions ConA I, A, All, H' and HII were
tested for their ability to displace 125I-oPRL
bindina to snake kidnev membranes. Different
amounts of oPRL bGH fractions
ConA I A All h
and H' II were incoroorated in
the assay medium to test for their potency in
displacing 125I-oPRL binding to snake kidney
membranes.
Amount of hormoneprotein per tube
in the assay. The potency of fraction H' was slightly lower.
Fraction ConA I showed a low potency in the assay and fraction
All was inactive in displacing 125I-oPRL binding to snake large
intestine membranes( Figure 4.31).
4.9.6 Radioiodination of fractions All and H'll
The iodination of fractions All and H'll were performed at
room temperature by the modified lactoperoxidase method
( Thorell and Johansson, 1971; Cheng et al., 1984) similar to
the iodination of bGH and oPRL. To 5 iq (2.5 tl) of the
fractions in a microcentrifuge tube, 1 mCi Na125I, 20 fil sodium
acetate buffer( 0.4 M, pH 5.6), 5 ixq lactoperoxidase in 10 xl
of the acetate buffer, and lOOng (10 1) of hydrogen peroxide
were added with constant flicking. After 1 minute the reaction
was stopped by addition of 0.1 ml transfer buffer( 10 mM
sodium phosphate, 1% potassium iodide, 16% sucrose and 0.1%
sodium azide, pH 7.5), followed by 50 fil of 5% BSA. To remove
unreacted 125i and damaged proteins, the reaction mixture was
fractionated on a column (50 cm x 1 cm) of Sephadex G-100
previously equilibrated with 0.01M sodium phosphate, 0.15M
sodium chloride pH 7.6. There were two radioactivity peaks
observed( Figures 4.32 and 4.3 3). The first broad and low
radioactivity peak represented iodinated proteins. The later
high radioactivity peak represented free 125I. The specific
activities were 47.30 Cijtxg for iodinated fraction All and
4 6.54 jLCifjuq for iodinated fraction HII as determined by the
Figure 4.31 Effects of A-derived and H'-derived fractions
on binding of 125I-oPRL to snake large intestine
membranes.
Fractions ConA I, A, All, H' and H'll were
tested for their ability to displace 125I-oPRI
hi nrl J n rr+- r cna Vd 1 pi rrro i nf ocf l no mombiy~a noc:
Hi ffprpnt amnnnR of nPRT
fractions ConA I
and H11]
the assay medium to test for their potency ir
displacing 125I-oPRL binding to large intestine
membranes.
Amount of hormoneprotein per tube
Figure 4.32 Iodination profile of 125I-labeiled fraction
All.
1 ml fractions were collected from a Sephadex
G-100 column (50cmxlcm), eluted with 10 mM
sodium phosphate, 0.15 M sodium chloride,
pH 7.6. The native 125I-labelled fraction All.
in fractions 33 to 3 5 was aliquoted and stored
at -20°C for binding assay. Values represented
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Figure 4.33 Iodination profile of 125I-labelled fraction
H'll.
1 ml fractions were collected from a Sephadex
G-100 column (50cmxlcm), eluted with 10 mM
sodium phosphate, 0.15 M sodium chloride,
pH 7.6. The native 125I-labelled fraction H'll
in fractions 34 to 36 was aliquoted and stored
at -20°C for binding assay. Values represented
the radioactivity counted from 5 nl of each
fraction.
method of trichloroacetic acid precipitation( Shiu and
Friesen, 1974).
4.9.7 Binding of 125-labelled fractions All and H'll to
mammalian membranes
The 125I-labelled fraction All and 125I-labelled fraction
H' II were tested for their abilities to bind to mammalian
membranes. The binding of 125I-labelled fraction All to female
rat liver membranes can be displaced by increasing amounts of
fraction All itself. BGH can compete for the binding and
showed a higher potency. OPRL can also displace the binding of
125I-labelled fraction All from rat liver membranes but with a
much diminished potency( Figure 4.34). In another assay the
result was similar. Fraction H'll was also tested for its
ability to displace the binding of 125I-labelled fraction All
to rat liver membranes. Fraction H'll had only low activity in
the assay( Figure 4.35). 125I-labelled fraction All was also
able to bind to liver membranes prepared from late pregnant
rabbits. BGH can compete for the binding of 12fI-labelled
«
fraction All and showed the highest potency in the assay.
Fraction H'll showed a low potency in the assay. Fraction All
and oPRL can also bind to the membrane but they had lower
potencies as compared to the potency of bGH( Figure 4.36).
•125I-labelled fraction H'll showed a low degree of binding
to female rat liver membranes. The binding of 125I-labelled
Figure 4.34 Displacement curves of binding of 125I-labelled
fraction All to female rat liver membranes.
Different amounts of oPRL hfiH
and fraction All wprp innnrnnratprf in
the assay medium to test for their ability in
displacing the binding of 125I-labelled
fraction All to female rat liver membranes.
Amount of hormonpnrotoin ner tube
Figure 4.35 Displacement curves of binding of 125I-labelled
fraction ATT to female rat liver membranes.
ni fforpnf amount«: of nPP
fraction AT
were incorporated in the assay medium to test
for their ability in displacing the binding of
125j_iabelled fraction All to female rat liver
membranes.
Amount of hormoneprotein per tube
Figure 4.36 Displacement curves of binding of 125I-labelled
fraction All to late pregnant rabbit liver
membranes.
Different amounts of oPRL
fraction All and f rant inn R'TT
were incorporated in the assay medium to test
for their ability in displacing the binding of
125i_iabelled fraction All to late pregnant
rabbit liver membranes.
Amount of hormoneprotein per tube
fraction H'll to mammary gland membranes prepared from late
pregnant rabbits and rat prostate membranes was also low and
insignificant.
4.9.8 Binding of 125I-labelled fractions All and H1!! to
snake membranes
The specific binding of 125I-labelled fraction All to
snake membranes was determined by RRA as described in Chapter
2. Each assay tube contained 1 mg of membrane proteins except
for those membrane preparations with a protein concentration
lower than 10 mgml. The non-specific binding of 125I-labelled
fraction All to the membranes was determined by incorporating
1 fig of fraction All in the assay tube. Table 4.1 showed the
results. Among the membranes studied, there was no significant
specific binding observed.
The specific binding of 125I-labelled fraction H'll to
snake membranes was determined by RRA as described in Chapter
2. Each assay tube contained 1 mg of membrane proteins except
for those membrane preparations with a protein concentration
lower than 10 mgml. Non-specific binding to the membranes was
%
determined by incorporating 1 fig of fraction H'll in the assay
tube. Table 4.2 showed the results. Among the membranes
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Table 4.1 Specific binding of 125I-labelled fraction All to
snake membranes.
The specific binding of 125I-labelled fraction All to
snake- membranes was determined as described in
Materials and Methods. Values shown are the
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Table 4.2 Specific binding of 125I-labelled fraction H'll to
snake membranes.
The specific binding of 125I-labelled fraction H'll
to snake membranes was determined as described in
Materials and Methods. Values shown are the
means+ SD of duplicate determinations.
4.10 Discussion
Alkaline extraction followed by precipitation was commonly
used in the purification of PRL•( Farmer et al., 1977; Chang
and Papkoff, 1985) because PRL is a small acidic protein.
Precipitation by ammonium sulphate was not employed in the
present study to purify the hormone because there was only a
very small amount of sample available.
It is possible that proteolytic enzymes can cause
artefactual displacement in the RRA. Iodinated fraction All
can bind to female rat liver and late pregnant rabbit liver
membranes. The binding can be displaced by bGH and fraction
All itself. Fraction All might not contain proteolytic enzymes
because 125-labelled proteolytic enzymes cannot show specific
binding to somatogenic receptor and show a displacement effect.
In both rat and rabbit liver membranes bGH showed high potency
in displacing the binding of 125I-labelled fraction All. The
potency of oPRL in the binding study is lower than that of
fraction All. The result suggested that fractipn All was
relatively pure and showed affinity to the binding to mammalian
somatogenic receptor.
Fraction H'll was less pure than fraction All.
Electrophoretic analysis of fraction H'll still showed multiple
bands. 125I-labelled fraction H'll showed no binding affinity
to both mammalian and snake membranes. It was possible that
fraction H'll was not pure enough so that the iodinated
fraction H'll was very heterogeneous. The binding of the
active component in fraction H'll may be overwhelmed by the
impurities contained in the fraction. Moreover, the low
molecular weight of fraction H'll may reveal the presence of
degraded forms of PLA. Fraction H'll may represent degraded
fragments of PLA which was incapable to bind to snake
membranes. Fraction H'll however showed displacement effect in
the binding of 125I-oPRL to snake kidney and large intestine
membranes. It suggested a possibility that the endogeneous
ligand for the PRL binding sites on snake kidney and large
intestine membranes was contained in the fraction H'll.
125I-labelled fraction All showed no specific binding to
snake membranes. It may represent an absence of somatogenic
sites in snake membranes because 125I-bGH also showed no
significant binding (see Chapter 3). It is also possible that
the binding sites for snake GHLA or bGH are present in low
levels. l25I-labelled fraction H'll showed no specific binding
to snake membranes but 125I-oPRL showed significant specific
binding to snake kidney and large intestine membranes. The
absence of specific binding of 125I-labelled fraction H'll may
be a result of the heterogeneity of the fraction. Moreover,
the low molecular weight of fraction All may reveal the
presence of degraded forms of GHLA. Fraction All may represent
degraded fragments of GHLA which was incapable of binding to
snake membranes.
In the present study PLA was traced by its ability to
displace 125I-oPRL binding to female rat liver membranes.
Prunet and Houdebine (1984) also employed PRL RRA to trace the
presence of PRL during the purification of the hormone from
chinook salmon pituitaries. The biological activity of the
purified chinook salmon PRL was confirmed by testing its
ability to induce casein synthesis in rabbit mammary cells.
The present study employed only PRL RRA to trace the presence
of PLA during the purification of PLA from snake pituitaries.
The presence of snake PLA should be confirmed by testing its
biological activities such as the lactogenic activity and the
sodium-retaining activity. There are many bioassays for PRL.
Stimulation of pigeon crop sac is a classical bioassay.. for
testing the lactogenic activity of PRL. Chang and Papkoff
(1985) had employed the pigeon crop sac assay to characterize
purified turtle PRL. The sodium-retaining assay in tilapia
tests for the osmoregulatory function of PRL. Farmer et al.
(1977) have employed this assay to confirm the biological
activity of tilapia PRL. Similar methods were also employed by
Kawauchi (1983) to purify chum salmon PRL.» Yamamoto et al.
(1986) had employed a heterologous RIA to purify toad PRL. The
purified hormone was confirmed by testing its activity in
stimulating collagen synthesis of tail fin tissue from tadpoles
after injection of the hormone. All these bioassays require
injection of the hormone into the experimental animals which
may' consume large amount of samples. The method of Prunet and
Houdebine (1984) may require less amount of samples. They
tested for the ability of PRL to stimulate casein synthesis in
cultured mammary gland cells. The method was applicable to
Chinook salmon PRL. Fraction H'll should be tested for its
biological activity by in vivo or in vitro bioassays. It is
possible that the PRL RRA has detected a protein which can only
bind to PRL receptor but with no biological activity.
Similarly, fraction All (GHLA) should be tested for its
somatogenic activity by means of in vivo or in vitro bioassays.
The present study demonstrated the presence of GHLA and
PLA in snake pituitaries. Snake GHLA and PLA are non-
glycoproteins which can be separated by ion-exchange
chromatography on DEAE-cellulose. Snake GHLA is unadsorbed to
DEAE-cellulose while snake PLA is adsorbed. This suggests that
ion-exchange chromatography on DEAE-cellulose is a useful tool
in the purification of GHLA and PLA from snake pituitaries. Gel
filtration, on the other hand, is not capable of separating
GHLA and PLA probably because of similar molecular weights.
Further purification of snake GHLA and PLA may employ
techniques with high resolutions like HPLC or•re-chromatography
of the partially purified GHLA( fraction All) and PLA
( fraction H'll) on DEAE-cellulose or CM-cellulose. Li et al.
(1987a and 1987b) have employed HPLC to purify PRL and GH from
elephant pituitaries. Yamamoto et al.. (1986) have also
purified toad PRL by means of HPLC. Moreover, only the
fractions with highest absorbance values at the peak position
should be collected instead of collecting all the fractions
representing the whole absorption peak. The snake PLA and
GHLA were only tested for its abilities to displace 125I-oPRL
and 125I-bGH from binding to female rat liver membranes in the
present study. Both fractions All and H'll should be tested by
in vitro or in vivo bioassays to confirm their biological
activities.
CHAPTER 5 DISCUSSION AND CONCLUSION
The present study described the distribution of bGH
binding sites in snake membranes( Table 3.1). There is no
previous report on the binding of 125I-bGH to membranes of
reptilian species. Marques et al. (1979) have reported the
concentration of 125I-bGH in turtle kidney and liver after
injection of 125I-bGH into the animal. But no significant
specific binding of 125I-bGH was observed in snake kidney and
liver membranes in the present study. 125I-bGH specific
binding was found in the membranes prepared from snake lung and
the gastrointestinal tract. Specific bGH binding site in lung
membrane was also demonstrated by Amit et al. (1987) in adult
rabbit. There are no reports on specific GH binding site in
the membranes from gastrointestinal tract but GH was reported
to be active in mediating the intestinal absorption of water
and ions in rat( Mainoya, 1975 and 1982). The possible
involvement of GH in intestinal function in snakes is still
obscure. It is difficult to assess the significance of
somatogenic sites in snake lung and gastrointestinal tract
because the specific binding of 125I-bGH to these membranes was
low and the non-specific binding was high. Further
characterization of I-bGH binding to snake membranes' is
difficult because of the high degree qf non-specific binding
which tend to obscure the binding data. The limited
availability of a large amount of membrane preparation is also
an inhibiting factor.
Specific binding of 125I-bGH to liver membranes was
evident in many mammalian species( Posner et al., 1976; Ranke
et al., 1976; Hung and Moore, 1984) and fishes( Tarpey and
Nicoll, 1985), but the absence of liver bGH binding site was
observed in pigeon, turtle, bullfrog, tilapia and leopard shark
( Tarpey and Nicoll, 1985 and 1987). The absence of bGH
binding in the snake liver may be caused by a high level of
endogenous GH which occupies the liver GH binding sites so that
no GH binding site can be detected. The result may also
suggest a total absence of liver GH binding sites in snakes.
The GH binding sites in snakes may show only very low affinity
to bGH because the endogenous ligand of the snake may be
different from bGH. Using a homologous RRA specific GH binding
sites were shown in liver membranes from tilapia( Fryer,
1979a) and chicken( Leung et al., 1984). 125I-labelled
tilapia GH also bound specifically to liver membranes from
other fish species. In present study the partially purified
GHLA( fraction All) was iodinated and tested for its ability
to bind to snake membranes. No significant binding of 125i-
labelled fraction All was observed in snake membranes. This
may indicate a total absence of somatogenic receptors in
snakes, or the saturation of the somatogenic receptors by high
levels of endogeneous snake GH. Moreover, the purity o.f
fraction All is not high enough. The .impurities in fraction
All and the non-specific binding may overwhelm the specific
binding of 125I-labelled fraction All to snake membranes. It
is also possible that the fraction All is only a degraded
fragment of snake GHLA so that it cannot bind to snake
membranes. Highly purified reptilian GH or snake GH should be
used to study the snake somatogenic receptors.
Specific binding of 125I-oPRL was found in snake kidney
and large intestine membranes. Specific binding was higher
than 5% of the total 125I-oPRL added. Slight( 1-5%) specific
binding of 125I-oPRL was also detected in membranes from snake
lung( male only), pancreas( male only), testis, oesophagus
and small intestine( Table 3.2). Specific oPRL binding was
also found in kidney membranes from reptiles( Nicoll et al.,
1980) and turtle( Tarpey and Nicoll, 1987). Renal oPRL
binding sites were also found in many vertebrate species
including tilapia( Fryer, 1979b; Edery et al.. 1984),
bullfrog( White and Nicoll, 1979; White, 1981; Tarpey and
Nicoll, 1987), green frog( d'Istria et aJL., 1987), bird
( Nicoll et al., 1980), rat( Marshall et al., 1975; Mountjoy
et al., 1979) and many other amphibian species( White, 1981;
Nicoll and White, 1982; Dunand et al.. 1985; Guardabassi
et al., 1987; Tarpey and Nicoll, 1987). The high specific
oPRL binding in snake kidney membranes was consistent with the
specific oPRL binding in other representative vertebrate
groups. There is no report on the specific oPRL binding site
in intestine membrane. The specific binding of 125I-oPRL in
snake large intestine membrane may reveal a possible
involvement of PRL in the function of large intestine in
snakes. Specific PRL binding was absent in snake liver
membrane. The presence of specific PRL binding site in liver
membranes was found in many mammals, tilapia( Edery et al.,
1984) and many avian species( Buntin et al., 1984) but not
in amphibians( White, 1981; Nicoll and White, 1985) and
fishes( Nicoll and White, 1985). The absence of specific PRL
binding sites in snake liver membrane may reveal a lack of
liver PRL receptor in snakes in the phylogeny of the hepatic
PRL receptor.
The presence of PRL binding sites in snake and large
intestine membranes indicates that these organs may be the
target organs of the hormone, playing possibly an
osmoregulatory role. There are only very few reports on the
physiological functions of PRL in reptiles( Chan et ajL., 1970;
Brewer and Ensor, 1980a and 1980b). The osmoregulatory
function of PRL is evident in many species including many
fishes and amphibians. The role of kidney as the target organ
of PRL is emerging. Specific binding of PRL to kidney
membranes is evident in many species including rat, amphibians,
turtle and teleosts. Fortner and Pickford (1982) have
demonstrated the sodium-retaining activity 6f PRL in fishes.
Hasegawa et al. (1986) obtained similar results. Moreover a
direct stimulatory effect of PRL on renal Na+-K+-ATPase
activity in rat was also reported( Pippard and Baylis, 1986;
Bussieres et al., 1987). The presence of specific PRL binding
site in snake kidney and large intestine membranes suggests a
putative osmoregulatory function of PRL in snakes.
Chan et al. (1970) have reported that PRL treatment can
lower plasma sodium level in the hypophysectomized lizard
Dipsosaurus dorsalis. However, Brewer and Ensor (1980a) have
demonstrated that PRL can increase the glomerular filtration
rate in terrapins. In the tortoise Testudo graeca, PRL also
produced a reduction in urine volume, and a rise in potassium
and magnesium concentrations in intact animals (1980b). All
these results pointed to a renal function of PRL in reptiles
but the exact physiological function of PRL in snakes is still
obscure. The purification of snake PRL may be useful in
elucidating the physiological functions of PRL in snakes.
Prunet et al. (1985) have used a specific RIA for salmonid PRL
to study plasma and pituitary PRL levels in rainbow trout. It
is also possible to raise a specific antiserum against the
purified snake PRL which can be used to develop a RIA for the
snake PRL. A sensitive RIA is useful in determining the
endogeneous PRL level in various seasons and physiological
states.
The present study identified the presence of GHLA and PLA
in snake pituitaries. Both snake GHLA and PLA are non-
glycoproteins. Snake GHLA has a high pi value and is
unadsorbed to DEAE-cellulose while snake PLA was adsorbed. In
SDS-polyacrylamide gel electrophoresis the partially purified
snake GHLA( fraction All) showed a molecular weight of about
19,000 daltons while the partially, purified snake PLA
( fraction H'll) showed a molecular weight of only 16,000
daltons. Apparently there are two distinct molecules. Snake
GHLA has a higher molecular weight and shows an unique activity
in binding to somatogenic receptors. Snake PLA is a smaller
protein which can bind to both somatogenic and lactogenic
receptors.
The presence of PLA in snake pituitaries and its ability
to displace 125I-oPRL from binding to snake kidney and large
intestine membranes corroborate the osmoregulatory role of the
hormone. The present study also demonstrated the existence of
GHLA in snake pituitaries, but its role in this reptile is not
understood, particularly when no specific binding can be found
in snake tissues using either bGH or partially purified snake
GHLA as the ligand.
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